WO2001047597A2 - Information network interrogation of an implanted device - Google Patents

Information network interrogation of an implanted device Download PDF

Info

Publication number
WO2001047597A2
WO2001047597A2 PCT/US2000/034486 US0034486W WO0147597A2 WO 2001047597 A2 WO2001047597 A2 WO 2001047597A2 US 0034486 W US0034486 W US 0034486W WO 0147597 A2 WO0147597 A2 WO 0147597A2
Authority
WO
WIPO (PCT)
Prior art keywords
imd
network
data
patient
computer
Prior art date
Application number
PCT/US2000/034486
Other languages
French (fr)
Other versions
WO2001047597A3 (en
WO2001047597B1 (en
Inventor
Charles R. Stomberg
Jean Ringold
Ronald A. Stauffer
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic, Inc. filed Critical Medtronic, Inc.
Priority to EP00986575A priority Critical patent/EP1244382A2/en
Publication of WO2001047597A2 publication Critical patent/WO2001047597A2/en
Publication of WO2001047597A3 publication Critical patent/WO2001047597A3/en
Publication of WO2001047597B1 publication Critical patent/WO2001047597B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37264Changing the program; Upgrading firmware
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37282Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data characterised by communication with experts in remote locations using a network
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/40ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7217Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/60ICT specially adapted for the handling or processing of medical references relating to pathologies

Definitions

  • the present invention generally relates to implantable medical devices (IMDs). Specifically, the invention pertains to an information network for remotely directing patient device data retrieval and device instruction updates. More specifically, the invention enables autonomous interrogation of the IMDs, without the intervention of an operator or a clinician, in real time. The collected data may be reviewed by a clinician or may be archived to compare patient history and for other future use. An interface medical unit or a programmer may be used to uplink the IMDs to the remote information network.
  • IMDs implantable medical devices
  • IMDs may also contain logic devices such as digital controllers, which may need to undergo firmware or software upgrades or modifications.
  • information about the IMD may be gathered for treatment or research purposes. For example, many IMDs are capable of storing certain state information or other data regarding their operation internally in addition to physiological data.
  • IMD operation and patient physiology is preferably monitored to help effect the desired patient outcome, it would be desirable if data collected by an IMD could be viewed remotely. Similarly, it would also be desirable that the instructions installed in an IMD may be modified in response to patient physiologic information, or perhaps be upgraded remotely as well.
  • an implanted cardioverter defibrillator may administer to the host patient a cardioversion or defibrillation therapy. After such therapy, it is typically desirable to determine the parameters of, for example, an arrhythmia that a therapy was administered in response to, or of the therapy administered.
  • IMDs are in a unique position to monitor physiological systems continuously. High-resolution data can be collected, but implantable devices are ill suited to storage and processing of large amounts of complex physiological data.
  • computing power and data storage capacity is abundantly available in the non-implantable (“external") world.
  • the computing industry is still following Moore's Law (stating that transistor density will double every 18 months), delivering increasingly sophisticated computing devices yearly, and some of these gains accrue to the computer power of IMDs.
  • Moore's Law stating that transistor density will double every 18 months
  • delivering increasingly sophisticated computing devices yearly and some of these gains accrue to the computer power of IMDs.
  • frequent upgrading and replacement of IMDs based on more powerful models subjects a patient to additional stresses, and additional costs are imposed on the patient or health care system.
  • Prior art methods of clinical services are generally limited to in-hospital procedures or other scenarios involving patient transportation to a clinical setting. For example, if a physician needs to review the performance parameters of an IMD in a patient, it is likely that the patient has to go to the clinic. Further, if the medical conditions of a patient with an IMD warrant a continuous monitoring or adjustment of the device, the patient would have to stay in a hospital indefinitely. Such a continued treatment plan poses both economic and social problems. Under the prior art, as the segment of the population with IMDs increases, many more hospitals and clinics, and attendant clinicians and service personnel will be needed to provide in-hospital service for the patients, thus escalating the cost of healthcare. Additionally, the patients will be unduly restricted and inconvenienced by the need to either stay in the hospital or make very frequent visits to a clinic.
  • the report contain the identification of all the medical devices involved in any interactive procedure. Specifically, all peripheral and major devices that are used in downlinking to the IMD may be reported.
  • Currently, such procedures are manually reported, and require an operator or a medical person to manually enter data during each procedure.
  • One of the limitations of such manual reporting procedures is the possibility for human error in data entry, thus motivating rechecking of the data to verify accuracy.
  • the use of human clinicians and technicians to analyze data and implement changes in device therapy can result in inefficiencies and errors.
  • a further condition of the prior art relates to the interface between a human operator and a programmer system.
  • clinicians such as pacing clinicians may be made available to implement desirable changes in the treatment regimen effected by an IMD.
  • a medical device manager/technician should be trained on the clinical and operational aspects of the programmer. Under current practices, a technician may attend a class or training session sponsored by a clinic, a hospital, or the manufacturer to successfully manage a programmer-IMD procedure. Further, ideally the operator will keep abreast of new developments and new procedures in the management, maintenance and upgrade of the IMD.
  • IMDs and medical instruments such as programmers; and between operators and entities providing IMD updates and education such as manufacturers.
  • clinician communication and training it may be desirable to automate device administration, maintenance, and upgrading to the extent possible in order to ensure that device instructions and data are appropriate to the situation.
  • a further limitation of the prior art relates to the management of multiple medical devices in a single patient.
  • Advances in modern patient therapy and treatment have made it possible to implant a number of devices in a patient.
  • IMDs such as a defibrillator or a pacer, a neural implant, a drug pump, a separate physiologic monitor and various other IMDs may be implanted in a single patient.
  • To successfully manage the operations and assess the performance of each device in a patient with multi-implants may require frequent update and monitoring of the devices.
  • the present invention provides a system for directing remote interrogation of
  • the invention may be used to reduce or eliminate the need for a clinician or other person available to administer device interrogation.
  • the invention may also create a means for gathering device data in advance of its actual review of a clinician.
  • a remote interrogation will preferably allow clinicians to review data intermittently, even while an IMD is still accessing or adding to the same body of data as stored in memory on-board the IMD.
  • a computer remote to the host patient may initiate and subsequently store the contents of IMD device memory interrogated and transmitted to the remote computer. This data would then be available for examination in the future. For example, a referring physician could use the ability to examine the patient remotely as a consultation system.
  • a technology-based health care system that fully integrates the technical and social aspects of patient care and therapy will preferably flawlessly connect the client with care providers irrespective of separation distance or location of the participants.
  • a programmer unit that would connect to a centralized data source and repository.
  • This may be termed, for example, a remote interrogator, or a remote data center.
  • This remote data center will preferably provide access to an expert system allowing for downloading of upgrade data or other information to a local, i.e., IMD environment.
  • IMD environment i.e., IMD environment.
  • the data system contemplated by the present invention enables an efficient system for data storage, collection and processing to effect changes in control algorithms of the
  • IMDs and associated medical units to promote real-time therapy and clinical care.
  • the proliferation of patients with multi-implant medical devices worldwide has made it imperative to provide remote services to the IMDs and timely clinical care to the patient.
  • the use of programmers and related devices to communicate with the IMDs and provide various remote services has become an important aspect of patient care.
  • the use of programmers may be implemented in a manner consistent with the co-pending applications detailed in the foregoing Cross Reference to Related Applications, and assigned to the assignee of the instant mvention.
  • the present invention provides a vital system and method of delivering efficient therapy and clinical care to the patient.
  • one or more IMDs such as a pacemaker, defibrillator, drug pump, neurological stimulator, physiological signal recorder may be deployed in a patient.
  • the IMD may be equipped with a radio frequency transmitter or receiver, or an alternate wireless communication telemetry technique or media which may travel through human tissue.
  • the IMD may contain a transmission device capable of transmitting through human tissue such as radio frequency telemetry, acoustic telemetry, or a transmission technique that uses patient tissue as a transmission medium.
  • an IMD may be deployed in a configuration where a transmission or receiving device is visible externally to the patient but is connected directly or via wires to the IMD.
  • IMDNI IMD Network Interface
  • IMDNI an external device, which may generally be termed an IMD Network Interface (IMDNI)
  • IMDNI may be positioned outside the patient, the IMDNI being equipped with a radio frequency or other communication means compatible with the communication media of the IMD or the IMD transmitter/receiver, which may be external to the IMD and may further be external to the patient.
  • IMDNI contains a radio frequency transmitter/receiver or similar radio frequency telemetry device. Communication may be effected between the IMD transmitter/receiver and the external IMDNI, e.g. via radio frequency.
  • the IMDNI will be connected via a wireless or physical communication media, e.g.
  • the IMDNI may have a direct connection or tunneled connection directly to the centralized computing resource.
  • the system may be implemented as a data network that allows the IMDNI access to the computing center from many locations, for example providing for a IMDNI that is portable.
  • long-term disease progression e.g. heart failure, hypertension, diabetes
  • therapies may be adjusted with finer granularity and improved results, with reduced need for human intervention and reduced opportunity for clinician error.
  • the amount of historical data, particularly patient-specific historical data used as input to control systems can be virtually unlimited when it is stored externally to the patient. Furthermore, a more thorough comparison can be made between patients with similar diseases as data and therapy direction are centralized, which may be expected to result in gains to the body of medical knowledge and treatment efficacy. Data from other medical systems, either implanted or external, such as etiological databases, can be incorporated easily into the control system. Other anonymous patient experiences or treatment data may be more quickly incorporated into a subject patient's IMD regime than might be possible with existing systems of IMD programming or upgrading. In addition, a subject patient's own historical treatment parameters and corresponding outcomes may be used in making IMD programming and other treatment decisions.
  • the instant invention provides IMDs with access to virtually unlimited computing power as part of their data collection and therapy calculation processes.
  • the IMD may be used by an external computing device as a data collection agent, and as an agent to implement changes to a treatment regimen based on a complex dynamical or stochastic physiological model.
  • the present invention provides a link with external computing power, which is more easily upgraded.
  • control system algorithms based on current knowledge about physiologic systems could be more easily updated using a centralized powerful processor, rather than individually updating the firmware or software of thousands of deployed IMDs.
  • the data and therapy from these IMDs may be more easily and efficiently orchestrated, thus further improving treatment efficacy and convenience to the patient and clinician, and in some cases judiciously limiting clinician involvement.
  • high resolution or finely grained data may be collected and stored from a vast number of subject IMDs. This finely grained patient data may be expected to prove valuable in defining and modifying an individual patient's treatment regimen as implemented by an IMD.
  • this high-resolution data may be analyzed on a mass scale, providing opportunities for improvement of existing physiologic models. This data may serve, for example, to validate physiologic models being employed, or may suggest refinement of these models based on numerous patient outcomes.
  • an embodiment of the present invention permits the use of complex control systems to manage therapy of implantable medical devices.
  • the invention permits the orchestration of the data collection and therapy functions of IMDs, particularly the functions of multiple IMDs implanted in one patient.
  • an embodiment of the present invention permits of centralized therapy prescription, and provides the ability to compare disease states, diagnostic data and therapy prescription across patients with fine granularity. The ability to update control system software and hardware at a central location is also provided, as well as the ability to upgrade the firmware or software in distributed deployed IMDs from one central location.
  • a communications system provides the ability to have high-power computing systems interact with implanted medical devices, thus providing the ability to use complex control algorithms and models in implanted medical devices.
  • implanted medical devices thus providing the ability to use complex control algorithms and models in implanted medical devices.
  • relatively simple modeling, or in stochastic models relatively large amounts of historical data from a single or multiple medical devices may be brought to bear for predictive purposes in evaluating alternate therapy and IMD instruction prescriptions.
  • the present invention provides a system that establishes an external communications device and data network as a 'data bus' for extending the processing power of deployed IMDs, while minimizing host patient and clinician inconvenience.
  • the present mvention may be effected, in part, by the provision of an IMDNI device, which may be a standalone device or a computer peripheral device, that is capable of connecting an IMD, or simply data telemetrically received from an IMD, to a network or other data communication link.
  • an IMDNI device which may be a standalone device or a computer peripheral device, that is capable of connecting an IMD, or simply data telemetrically received from an IMD, to a network or other data communication link.
  • Network Interface or the like
  • the interface may serve as an interface to a variety of data communications systems, including not only networks, but also, without limitation, direct dial-up connections, dedicated lines, direct satellite links, and other non-network data communications connections.
  • a host patient i.e., a patient having an IMD implanted within, presents themselves to a IMD network interface device, or IMDNI.
  • This IMDNI will preferably have the capability of communicating with the IMD via wireless means, such as by radio transmissions.
  • the IMDNI may be placed, for example, in a patient's home, or may be available for use by several patients in a treatment facility such as a hospital, nursing home, or ambulatory care center.
  • data can be interrogated, with the aid of a remote interrogator device, by an IMDNI in an emergency room and then uploaded to an information network to which a remote interrogator is connected.
  • This information network may be according to any network protocol, for example, TCP/IP over the Internet.
  • the uploading to a central interrogation computer may also be effected over a direct dial-up connection or a dedicated line.
  • a medical professional or other clinician may be alerted to the fact the data has been uploaded. This clinician may then view the data.
  • a patient could also interrogate his or her device at home and upload it for a medical professional or clinician to view later.
  • Various scenarios according to the invention may provide convenient monitoring of IMD functioning to a host patient or clinician.
  • a patient may effect a test of their IMD with a device tests such as an exercise or stress test in a more natural or real life scenario that may provide more reliable or accurate results than a clinical evaluation, in addition to providing increased convenience to the patient and reducing the need for clinician or other professional attention.
  • a host patient may effect a dial-up connection to a remote interrogator following an afternoon walk in their neighborhood or on a treadmill in their home.
  • a home monitoring instrument may be provided to a host patient allowing the patient to send data, i.e., to effect remote interrogation, if, for example, they have a subjective belief that they are symptomatic.
  • a host patient of a cardioverter defibrillator IMD may effect remote interrogation if they believe they have suffered an arrhythmia event.
  • the data resulting from the remote interrogation may then be made remotely accessible for evaluation by a pacing system expert.
  • IMD f nction data and physiologic data of the host patient is made available nearly instantaneously to a clinician capable of evaluating the device function, physiologic event or data, or therapy administered by the target IMD.
  • the remote interrogator of the present invention is implemented as a software application which may be run on a server or central computer accessible via a network or direct connection by the IMDNI device.
  • the IMDNI may be implemented as a software client which may run on a computer remotely from the interrogator server.
  • the remote interrogator program or device is capable of autonomously and dynamically determining the model of an IMD, for example, according to manufacturer, type, and model number, as well as the specific serial number of a particular device.
  • the remote interrogator of the present invention is also preferably capable of configuring a deployed IMD, or commanding the IMDNI to retrieve data from the IMD.
  • an interaction between a deployed IMD and the remote interrogator may take place within a discrete session.
  • This session may encompass interrogation of one or more IMDs deployed in a single patient.
  • a session according to the present mvention may proceed according to the following scenario.
  • a host patient will typically present to an IMDNI.
  • the patient may place themselves in the vicinity of the IMDNI within range of the telemetry capacities of the IMDNI. This may take place at home in the case of a In Home Monitor (IHM) or at a medical facility such as an Emergency Room, Follow-up Clinic or Operating Room.
  • IHM In Home Monitor
  • the IMDNI may be programmed to issue a command to the target IMD to "Cancel Magnet", "Resume Therapy,” or another command to enter a mode consistent with the interrogation process.
  • the IMDNI Operator will effect a communications link between the IMDNI and the remote interrogation computer.
  • This IMDNI Operator may be a human attendant or technician, but preferably will be an automated module of the IMDNI firmware or software, or may be implemented as a software application on a general purpose computer connected to the IMDNI.
  • the remote interrogator computer may lead a human or automated
  • IMDNI through the steps of establishing a telemetry interface between the IMD and IMDNI; with the IMDNI in turn notifying the remote interrogator when a telemetry connection has been established.
  • Communication with the remote interrogation server may be established via a network connection, such as a LAN or WAN.
  • the operator may be the host patient of the target IMD, or it may be attendant personnel at a clinical setting. In either case, the operator may connect the IMDNI to a suitable network connection, if a network connection is not already in place.
  • a direct dial-up connection may be established in this manner by physically connecting the IMDNI into a telephone connection jack such as a RJ-11 analog jack. The operator at some point would turn the IMDNI on and cause the IMDNI system to dial a pre-configured telephone number. Alternately, other, more continuous types of network connections may also be established.
  • Figure 1 depicts a general network architecture diagram of a system embodying the subject invention.
  • Figure 2 depicts an implementation of the system of Figure 1 using specific hardware components.
  • Figure 3 depicts an alternate implementation of the system depicted in Figure 1, including additional hardware devices.
  • Figure 4 is an architectural drawing of an embodiment of the subject invention showing internal device architecture.
  • FIG. 1 depicts a general architectural view of a remote interrogation system according to an embodiment of the present invention.
  • An IMD polling and interrogation system 110 is provided.
  • IMD 112 has been deployed in a patient, for example, a patient at a location remote from remote interrogator connected to or within information network 114.
  • the IMD 112 may be one of a number of existing or to be developed IMDs, for example, a pacemaker, defibrillator, drug pump, neurological stimulator, physiological signal recorder, oxygen sensor, or the like.
  • a device external to the patient is provided which may be termed an IMD Network Interface, or IMDNI 116.
  • This IMDNI 116 may communicate with the IMD 112 via, e.g., radio frequency, as discussed above.
  • the IMDNI 116 may also communicate with a data network 114 via modem, LAN, WAN, wireless or infrared means according to network connections 118 and 120.
  • This data network 114 is preferably able to communicate via a computer network or other suitable data communications connection with a central computer within information network 1 14. While in Figure 1, a single IMD 112 is depicted, the subject invention permits of use with multiple IMDs deployed in a single patient, each making separate transmissions and receiving separate instructions from IMDNI 116. In an alternate embodiment of the subject invention, multiple IMDs deployed in a single patient are all linked to a single telemetry device implanted in a patient. This telemetry device may be separate from or incorporated into one of the IMDs deployed in a patient.
  • IMD 112 is equipped with or linked to a transmission and receiving device such as a radio frequency telemetry device, also preferably implanted in a patient.
  • the information network 114 computing center or central computer preferably has sufficient computing power and storage capability to collect and process large amounts of physiological data using complex control systems.
  • the patient is placed or places himself or herself in proximity to IMDNI 116.
  • IMDNI 116 may be placed in a patient's home, at their bedside perhaps, or may be placed in a community center, clinical office setting, nursing home, or other care facility.
  • IMDNI 116 may also be embodied in a portable device that may be carried by the patient while outside the home or traveling.
  • IMDNI 116 like IMD 112, contains or is linked to a communications media transmitter/receiver compatible with the type incorporated into or linked to
  • IMDNI 116 contains a radio frequency transmitter/receiver or similar radio frequency telemetry device establishing radio frequency link 118.
  • FIG. 2 depicts an implementation of the system of Figure 1 using specific hardware components.
  • information network 114 includes remote interrogator computer 220.
  • Remote interrogator 220 will preferably be possessed of appreciably more computing power than possible with an IMD 112, in terms of processor speed, RAM available, and other data storage.
  • Remote interrogator computer 220 is large scale in comparison to such processors that are available for incorporation into an IMD 112. For example, some commercially-available personal computers may contain sufficient computing power to operate as a server capable of carrying out many IMD 112 diagnostic, programming, and data storage tasks. In a preferred embodiment of the subject invention, however, remote interrogator 220 will be a back end data server, or a high end data server.
  • the computing device will be configured as a server capable of communicating directly or indirectly with IMDNI 116.
  • the computer 220 will preferably have sufficient storage, either internal to the computer or linked to the computer, for the storage of massive amounts of historical patient data from, for example, a particular patient having an IMD 112 in communication with computer 220, and/or subject data from relevant physiologic studies or from cohort groups having similar medical conditions and/or deployed IMDs.
  • remote interrogation computer 220 is linked to or contains data storage element 222.
  • Data storage element 222 may contain any suitable means of data storage, including but not limited to hard drive, or another readable/writable magnetic or optical storage.
  • data storage element 222 has a redundant array of disks such as a redundant array of inexpensive disks (RAID) system.
  • RAID redundant array of inexpensive disks
  • integrity of transmitted data and instructions will preferably be maintained so as to avoid adverse patient outcomes or patient outcomes that do not take full advantage of the subject invention.
  • patient information that may be linked to an identifiable individual is typically regarded as confidential.
  • encryption or tunneling will preferably be provided to ensure patient confidentiality, particularly when transmissions between IMDNI 116 and computer 220 takes place though media other than a dedicated line/direct dial-up connection, such as a packet-based network technology over a public network or internetwork. For example, if the transmissions are routed over the Internet using TCP/IP, encryption will preferably be used.
  • a proprietary data exchange format/interface that is kept secret may be used in communications between IMD 112 and IMDNI 116.
  • digital signatures will preferably be used to detect corruption of data.
  • Additional implementations of security systems may also be utilized in accordance with the subject invention, including biometric security apparatus and methods to detect inalterable physical characteristics of persons attempting to access the patient data in order to authenticate the would-be user of the system.
  • Security measures such as the foregoing will preferably be used to authenticate the IMDNI 116 and IMD 112, as well as persons attempting to access patient data, including a host patient.
  • a preferred embodiment of the subject invention utilizes digital signatures and encryption of the patient information and IMD 112 instructions being transmitted according to the present invention. Encryption of patient information will serve to protect patient confidentiality.
  • Each transmission of patient data will preferably have a digital signature that can be checked against the transmission payload to ensure that patient data and IMD 112 instructions were not corrupted during transmission.
  • Examples of encryption/digital signature schemes that should prove sufficient for suitable encryption of patient information and digital signatures include PGP, the RSA public key infrastructure scheme, or other consumer-level or higher, prime number based encryption signature scheme.
  • Biometric data used to authenticate and verify accessors of the data may include retina scans, iris scans, fingerprint scans, vein print scans, voiceprints, characteristics, facial geometry/facial recognition according to facial nodal points, or hand geometry scans.
  • a preferred embodiment of the subject invention incorporates firewall and/or proxy server technology, as indicated in Figure 2 at firewalls 226 and 228.
  • IMDNI 116 may communicate with a peripheral physiological data gathering device 232, which may for example be external to the host patient having implanted IMD 1 12.
  • IMDNI 116 may also communicate with additional devices as detailed in Figure 3, central information network 114 via a number of network schemes or connections, with regard to any of the OSI layers.
  • the network is depicted generally at network cloud 230.
  • communication may be effected by way of a TCP/IP connection, particularly one using the Internet, as well as a PSTN, DSL, ISDN, Cable Modem, LAN, WAN, MAN, direct dial-up connection, a dedicated line, or a dedicated terminal connection to a mainframe.
  • Various persons 118 including clinicians or the patient having IMD 112 installed may access the patient's data from information network 114, as described herein. This reduces the need for on-site clinical visits by the patient.
  • Transmissions between an IMD 112 and IMDNI 116 or between peripheral physiological data gatherer 232, or other peripheral devices will also preferably be protected from transmission errors using similar encryption, authentication, and verification techniques to those discussed above, and or wireless communication enhancement techniques such as wireless modulation or another suitable wide-frequency spectra technique.
  • encryption and/or authentication will be effected end-to-end, i.e., covering the entire transmission from IMD 112 to computer 220 or from computer 220 to IMD 112, rather than effecting one encryption/verification scheme between IMD 112 and IMDNI 116, and a different scheme between IMDNI 116 and computer 220.
  • radio frequency pulse coding spread spectrum, direct sequence, time-hopping, frequency hopping, a hybrid spread spectrum technique, or other wireless modulation techniques may be employed in order to reduce interference between IMD 112 and other IMD or other wireless devices, and to generally offer improved accuracy, reliability, and security to transmissions between IMD 112 and IMDNI 116, may be used to avoid cross-talk or confusion among IMDs and/or IMDNIs in proximity to each other.
  • radio coding may be implemented to avoid transmission errors or device confusion between neighboring IMD 112 patients utilizing a device implementing aspects of the present invention in a managed-care setting.
  • a data network is provided that allows the external communications device, or IMDNI 116, access to the computing center 220 from one of many possible locations. This provides portability to the administration of the IMDNI 116 and enhancement patient lifestyle.
  • a communications link is established over which the IMDNI 116 may establish a connection with the remote interrogator computer 220.
  • the initial communication may focus on authentication of the IMDNI 116. This will preferably include verification that the IMDNI 116 is certified for interrogating IMDs, i.e., a verification process has established that the software and hardware revisions are current, and that the authentication information uniquely identifies a specific known IMDNI 116.
  • the remote interrogator 220 may next instruct the IMDNI Operator such as a human user how to configure the telemetry mterface 118 between IMDNI 116 and IMD 112. This would typically be specific for the type of IMD 112 being interrogated and might involve, for example, placing a programming head or wand near the IMD 112, or just positioning the patient and IMDNI 1 16 in proximity.
  • the IMDNI 116 may then notify the remote interrogator computer 220 that a telemetry connection has been established.
  • a telemetry interface preferably remote interrogator
  • a device agent software module is selected to interface with a particular type or model of IMD 112.
  • the IMDNI 116 is configured to dynamically identify an IMD 112 presented to it for remote interrogation, preferably an initial IMD 112 identification stage precedes the selection of device agent module.
  • the IMDNI is pre-configured to work only with the specific device(s) implanted in an individual host patient of the residence.
  • the remote interrogator computer 220 may retrieve certain pertinent data from the IMD 112, including physiologic data regarding the host patient stored in IMD 112 memory, stored power remaining, amount of drug remaining within the device, or hardware, software, or firmware version information, or other device status information.
  • the remote interrogator 220 may signal the completion of the operation to IMDNI 116.
  • the remote interrogator 220 will then close the connection with IMDNI 116, for example after a disconnect request to the IMDNI 116, for example, as part of the implementation of a symmetric release to avoid possible loss of data.
  • the IMDNI 116 may then terminate the telemetry or other wireless connection with the IMD 112. This may involve the issuance of instructions to a human IMDNI Operator, if applicable, to effect the termination in a certain manner, for example, by removing the IMDNI 116 from proximity to the host patient.
  • the IMDNI 116 will not terminate communication with the IMD 112 until after the connection with the remote interrogator 220 is released.
  • Figure 3 depicts an alternate implementation of the system depicted in Figure
  • notifications or confirmations may be generated by remote interrogator 220.
  • remote data devices 310 such as a remote computer 312, fax machine 314, cellular telephone 316, or other data device which may be operated by or for individuals or entities interested in the target IMD 112 operation or host patient data.
  • the data may also be provided to remote patient in-home personal computer 318.
  • these notifications may be accompanied by relevant data, and are made only to devices or individuals that have been properly authenticated as having permission to view the patient data.
  • this data is preferably encrypted or digitally signed to preserve its confidentiality and for confirmation of data integrity.
  • Various data communications methods may be suitable for transmission of the target device and host patient data to a remote computer, including an SMTP e-mail, FTP, or TCP/IP.
  • properly authenticated interested parties may access the patient or device data, the data residing on a server such as the remote interrogator, via TCP/IP protocol using a web browser.
  • confirmation that the data has been retrieved successfully by the remote interrogator 220, or has been transmitted to a particular remote user such as a physician using remote computer 310 is transmitted to the site of collection and displayed on the IMDNI 116, or on a computer or other data device such as patient home computer 318.
  • a confirmation that a remote clinician, for example, a clinician that is located somewhere other than the site of the IMDNI data collection point, or from the remote interrogator 220, has accessed the data via remote computer 310, may be transmitted to the site of collection 116 or to another location or device 310 or 318.
  • This confirmation may be effected, for example, by a reply e-mail from a clinician that has received an SMTP message from remote interrogator 220, indicating that the data has been received or reviewed.
  • the present invention admits of various revenue-creating, or treatment administration or business applications.
  • a pre-appointment interrogation may be effected using the system outlined above in order that the clinician may have reviewed or analyzed the relevant host patient or target device data prior to an in-person appointment by a host patient.
  • a follow-up interrogation of a target device a certain prescribed time following an in-person appointment or other event may be provided for and automatically scheduled for execution by a IMDNI 116.
  • the IMDNI the IMDNI
  • the remote interrogation system described herein may be provided to a host patient or to a clinician or clinical entity on a subscription basis, or on a fee per use or per data access basis.
  • the deployed IMD 1 12 collects physiological data from the host patient via electrical, mechanical or chemical sensors, according to the type of IMD 112 deployed in the host patient. Some of this data may be used locally, i.e., processed and analyzed internally to the IMD 112 itself, to modify therapy or treatment on a 'real-time' basis.
  • IMDNI 116 may access and store data from an IMD programmer 320, interface medical unit 322, or in-home monitor 324.
  • the patient data will preferably be buffered, queued, or spooled in the IMD 112 until such time as the device is polled or "interrogated" by remote interrogator 220 using the IMDNI 116.
  • the IMDNI 116 may also pass instructions received from the remote interrogator 220 to the IMD 112.
  • IMDNI 116 may contact the computing center or central remote interrogator 220 and transmit the physiologic data uploaded from IMD 112 to IMDNI 116.
  • the powerful computer(s) at the computing center 220 may store and/or process the data, perhaps combining it with historical data of the same type from the same device, or perhaps with data from other implanted and medical devices.
  • the physiologic data may be combined with anonymous data from other demographic or clinical groups consisting of subjects which may have data relevant or generalizable to host patient 114.
  • comparisons of the data collected may be made with data from other patients with similar disease states, and therapy solutions constructed and compared.
  • the computing center may then transfer instructions on modifications to therapy and data collection to the IMDNI 116.
  • the IMDNI 116 transfers the instructions to the IMD 112 and may also collect an additional batch of data buffered in the IMD 112. This opportunity for communication between IMDNI 116 and IMD 112 may not be immediately present.
  • IMD 112 within a host patient may be located away from IMDNI 1 16 temporarily, if the host patient has left their house or clinical setting where the IMDNI
  • An alternate barrier to IMDNI 116 to IMD 112 communication may be a poor environment for the communication media employed between the IMD 112 and the IMDNI 116.
  • IMDNI 116 may also be held at the remote interrogator 220 or within IMDNI 116, for example, if the IMDNI 116 is carried by host patient as a portable device, and an analog connection for a modem or suitable network connection may not be available.
  • communication system 110 will operate asynchronously, permitting for the possibility for breaks in the continuous and real-time communications and/or processing of the three subsystems (IMD 112, IMDNI 116, and remote interrogator 220.
  • IMD 112, IMDNI 116, and remote interrogator 220 may also possible, including synchronous, "real-time" control of the target IMD 112. This alternate "real-time" embodiment of the system 110 may be enhanced upon the establishment of more ubiquitous and robust communications systems or links.
  • FIG. 4 is an architectural drawing of an embodiment of the subject invention showing internal device architecture.
  • IMD 112 effects the collection of high resolution physiological data; and provides for its temporary storage or buffering, for example in storage device 410.
  • This storage device is preferably a RAM module of a type suitable for implantation in IMDs.
  • IMD processor 412 Prior to storage in storage device 410, IMD processor 412 will preferably compress the physiologic data collected by physiologic sensor 414.
  • IMD processor 412 in addition to processing the reception and storage of physiologic data, also preferably effects implementation of IMD 112 therapy, through treatment administration device 416.
  • processor 412 may control the amount or frequency of electrical stimuli or drug delivered by treatment administration device 416. This control may be based on instructions originating from remote interrogator 220.
  • Figure 4 also depicts in greater detail the architecture of IMDNI 116 of Figure 1. As shown in Figure 4, IMDNI 1 16 contains a transmitter/receiver 420, a processor 422, storage device 424, and communication device 426. Communication device 426 may be, for example, a modem or network interface card.
  • IMDNI 116 contains architecture components similar to those seen in a computer, and in an alternate embodiment of the subject invention, the communication system 110 of Figures 1 -4 may be deployed with IMDNI 116 implemented as a computer with a peripheral device that may communicate with IMD 112. For example, IMDNI may be implemented together with a peripheral device to patient computer 318 of Figure 3.
  • communications between IMDNI 116 and remote interrogator 220 may be effected either through a network 230, such as a LAN or the Internet, or communications may be effected through a direct dial-up or dedicated line, or through a terminal connection to a mainframe.
  • a network 230 such as a LAN or the Internet
  • communications may be effected through a direct dial-up or dedicated line, or through a terminal connection to a mainframe.
  • communications link 430 are indicated generally by communications link 430.
  • these connections may be considered alternatives, or both communications links, i.e., relatively direct link 430 and link through network 230 may be implemented in order to provide a backup communications system to the link used as the primary communication method.
  • remote interrogator 220 creates an instruction file for IMDNI 116 and/or for IMD 112.
  • This file may consist largely of instructions for the IMD 112 affiliated with an IMDNI 116.
  • Remote interrogator 220 may then contact IMDNI 116 to initiate transfer.
  • this method of contact will correspond to the method of communication from IMDNI 116 to remote interrogator 220, although an alternate method may be used, particularly if a first preferred method proves unsuccessful. If communication with IMDNI 1 16 is possible, suitable instructions or information may be forwarded to IMDNI 1 16 for immediate or eventual communication to IMD 1 12.
  • IMDs 112 each with a separate identifying code or number, may utilize a single IMDNI 116. These several IMDs 112 sharing a IMDNI 116 may be deployed within a single patient, or the several IMDs 112 sharing a IMDNI 116 may be deployed in two or more separate patients, where each patient has reasonable access to the IMDNI 116 directly or to communications equipment which may send information to and receive information from IMDNI 116. While in an illustrative embodiment, several IMDNIs 116 share a remote interrogator 220, alternative embodiments may have a single IMDNI 116 communicating with distributed or parallel remote interrogators 220, in addition to or in place of remote interrogator 220.
  • an instruction regimen for a target IMD 112 may not be based solely on treatment considerations arising from patient data or from predictive modeling.
  • an instruction regimen may contain firmware or software upgrades to target IMD 112 which are prescribed generally for all host patients of a particular IMD 112 model or type.
  • an instruction regimen may be pushed or generally transmitted to IMDNI 116.
  • IMDNI 116 or equivalent may then store the results of processing or instruction carried out by remote interrogator 220, for example, as dictated by device agent server 224.
  • the IMD 112 instruction regimen prescribed by central computer 116 may be stored within IMDNI 116 indefinitely or for a fixed period of time prior to expiration.
  • IMDNI 116 provides new therapy programming, as well as new instructions for data collection if necessary.
  • IMDNI 116 if an instruction regimen has been received by IMDNI 116 for communication to target IMD 112, IMDNI 116 will periodically poll IMD 112 in attempts to establish a communication link, such as a wireless link.
  • a communication link such as a wireless link.
  • IMDNI 116 may have a display feature, which could be for example an LCD display or a simple indicator light indicating that an instruction regimen has been received for forwarding from central computer 220.
  • a human user for example, host patient of IMD 1 12 may press a button or otherwise initiate the process of communication between IMDNI 116 and target IMD 112.
  • IMDNI 116 is portrayed primarily as a self-contained or stand-alone unit, it will be appreciated that IMDNI 116 may also be implemented as a peripheral transmitter receiver capable of wireless communication with IMD 112, and also in communication with a computer such as patient home computer 318, such as a personal computer such as a laptop or portable computer. Computer 318 may also be a terminal of a remote computer 220.
  • IMDNI 116 is implemented as a peripheral and terminal
  • some of the components of IMDNI 116 may be implemented on a central computer 220 or storage device 222 rather than in the terminal implementing IMDNI 116.
  • the functions of IMDNI 116 of Figure 2 may be implemented in software resident on routing computer 318.
  • Communications interfaces of computer 318 when linked with IMDNI 116 may include a modem, network card, direct connection, or terminal connection.
  • preferably all data communication, security and message authentication and integrity confirmation as discussed above with regard to IMDNI 116 will be implemented on local computer 318.
  • Communication between IMDNI 116, and central computer 220 may be implemented via network 230 or via direct connection.
  • IMDNI 116 is implemented on a computer such as a PC 318 of Figure 3 with an IMDNI 116 transmitter/receiver peripheral device
  • a suitable pop-up message on the PC monitor may indicate a pending IMD 112 instruction or request, or an indicator on a display of the peripheral transmitter/receiver device 116 may indicate a pending instruction as above.
  • IMDNI 116 may send an error message identifying the IMD 112 and/or instruction regimen by a suitable code.
  • central computer 220 may be programmed to carry out suitable updating of an instruction regimen, or an error message may be output to remote devices 310, a human operator or clinician for direct intervention by voice telephony or direct contact by mobile clinical personnel, for example.

Abstract

A communication system is provided which permits of communication between a deployed implantable medical device (IMD) and a computing resource capable of storing and distributing patient and device data. A deployed IMD may be polled by a network interface external to the host patient, and data may be received by wireless communication. This data may be transmitted to a computer for storage and distribution, and changes to a treatment or instruction regimen, or firmware or software upgrades, may then be transmitted to the network interface for immediate or eventual loading into the IMD via wireless communication. The system is adapted to provide communication service between multiple IMDs deployed in a patient or a number of patients.

Description

INFORMATION NETWORK INTERROGATION OF AN IMPLANTED
DEVICE
FIELD OF THE INVENTION
The present invention generally relates to implantable medical devices (IMDs). Specifically, the invention pertains to an information network for remotely directing patient device data retrieval and device instruction updates. More specifically, the invention enables autonomous interrogation of the IMDs, without the intervention of an operator or a clinician, in real time. The collected data may be reviewed by a clinician or may be archived to compare patient history and for other future use. An interface medical unit or a programmer may be used to uplink the IMDs to the remote information network.
BACKGROUND OF THE INVENTION In the traditional provision of any medical services, including routine checkups and monitoring, a patient is required to physically present themselves at a provider's office or other clinical setting. In emergency situations, health care providers may travel to a patient's location, typically to provide stabilization during transport to a clinical setting, e.g., an emergency room. In some medical treatment applications, accepted medical practice for many procedures will naturally dictate physical proximity of medical providers and patients. However, the physical transport of patients to clinical settings requires logistical planning such as transportation, appointments, and dealing with cancellations and other scheduling complications. As a result of such logistical complications, patient compliance and clinician efficiency may suffer. In certain situations, delays caused by patient transport or scheduling may result in attendant delays in detection of medical conditions including life-threatening situations. It is desirable, therefore, to minimize situations in which the physical transport of a patient to a clinical setting is required. It may also be desirable to minimize the extent to which an patient or patient information must be considered by a clinician at a particular time, i.e. during an appointment. After the implantation of an IMD, for example, a cardiac pacemaker, clinician involvement with respect to the IMD has typically only begun. The IMD usually cannot be merely implanted and forgotten, but must be monitored for optimal results, and may require occasional adjustment of certain parameters or settings, or even replacement, in response to or in anticipation of changes in patient condition or other environmental factors, or based on factors internal to the device. IMDs may also contain logic devices such as digital controllers, which may need to undergo firmware or software upgrades or modifications. In addition, information about the IMD may be gathered for treatment or research purposes. For example, many IMDs are capable of storing certain state information or other data regarding their operation internally in addition to physiological data.
Because IMD operation and patient physiology is preferably monitored to help effect the desired patient outcome, it would be desirable if data collected by an IMD could be viewed remotely. Similarly, it would also be desirable that the instructions installed in an IMD may be modified in response to patient physiologic information, or perhaps be upgraded remotely as well.
In the event a change, modification or reprogramming of the IMDs is indicated, it would be desireable if the instruction could be implemented in the IMD as soon as possible, thus providing more continuous monitoring to proactively effect changes in the IMDs for efficient therapy and clinical care. This scenario may be contrasted with existing practice of responding to an adverse patient event or subjecting the patient to the inconvenience or expense of frequent in-person encounters with a clinician, for example after an unexpected therapy by the device, or to effect other monitoring of device functioning, e.g., spontaneous therapies by the device. For example, an implanted cardioverter defibrillator may administer to the host patient a cardioversion or defibrillation therapy. After such therapy, it is typically desirable to determine the parameters of, for example, an arrhythmia that a therapy was administered in response to, or of the therapy administered.
Despite the limitations of IMDs with regard to processing power, IMDs are in a unique position to monitor physiological systems continuously. High-resolution data can be collected, but implantable devices are ill suited to storage and processing of large amounts of complex physiological data. In contrast, computing power and data storage capacity (processor capability, memory, and adequate power supply) is abundantly available in the non-implantable ("external") world. The computing industry is still following Moore's Law (stating that transistor density will double every 18 months), delivering increasingly sophisticated computing devices yearly, and some of these gains accrue to the computer power of IMDs. However, frequent upgrading and replacement of IMDs based on more powerful models subjects a patient to additional stresses, and additional costs are imposed on the patient or health care system. Prior art methods of clinical services, particularly IMD monitoring and adjustment, are generally limited to in-hospital procedures or other scenarios involving patient transportation to a clinical setting. For example, if a physician needs to review the performance parameters of an IMD in a patient, it is likely that the patient has to go to the clinic. Further, if the medical conditions of a patient with an IMD warrant a continuous monitoring or adjustment of the device, the patient would have to stay in a hospital indefinitely. Such a continued treatment plan poses both economic and social problems. Under the prior art, as the segment of the population with IMDs increases, many more hospitals and clinics, and attendant clinicians and service personnel will be needed to provide in-hospital service for the patients, thus escalating the cost of healthcare. Additionally, the patients will be unduly restricted and inconvenienced by the need to either stay in the hospital or make very frequent visits to a clinic.
Yet another condition of the prior art practice requires that a patient visit a clinic center for occasional retrieval of data from the implanted device to assess the operations of the device and gather patient history for both clinical and research purposes. Such data is acquired by having the patient in a hospital/clinic to download the stored data from the IMD. Depending on the frequency of data collection, this procedure may pose serious difficulty and inconvenience for patients who live in rural areas or have limited mobility. Similarly, in the event a need arises to upgrade the software of an implantable medical device, the patient will be required to come into the clinic or hospital to have the upgrade installed. Further, it is a typical medical practice keep an accurate record of past and contemporaneous procedures relating to an IMD uplink with, for example, an IMD programmer, i.e. a computer capable of making changes to the firmware or software of an IMD. It is typically desired that the report contain the identification of all the medical devices involved in any interactive procedure. Specifically, all peripheral and major devices that are used in downlinking to the IMD may be reported. Currently, such procedures are manually reported, and require an operator or a medical person to manually enter data during each procedure. One of the limitations of such manual reporting procedures is the possibility for human error in data entry, thus motivating rechecking of the data to verify accuracy. Generally, the use of human clinicians and technicians to analyze data and implement changes in device therapy can result in inefficiencies and errors.
Yet a further condition of the prior art relates to the interface between a human operator and a programmer system. To aid a patient in the administration of a deployed medical device, clinicians such as pacing clinicians may be made available to implement desirable changes in the treatment regimen effected by an IMD. Generally, a medical device manager/technician should be trained on the clinical and operational aspects of the programmer. Under current practices, a technician may attend a class or training session sponsored by a clinic, a hospital, or the manufacturer to successfully manage a programmer-IMD procedure. Further, ideally the operator will keep abreast of new developments and new procedures in the management, maintenance and upgrade of the IMD. Accordingly, it is desirable that operators of programmers, IMDs, and related medical devices receive regular training or information about the IMDs they work with. This information will preferably be widely distributed, because IMDs, programmer devices, and related medical devices are distributed throughout the world. Further, the number of people having implanted medical devices has been increasing over the last few years, with an attendant increase in operator personnel. The total effect of these phenomenon is a widely dispersed and large body of operators. Thus, it is desirable to have a high efficiency communications system that would enhance data communications, both between the
IMDs and medical instruments, such as programmers; and between operators and entities providing IMD updates and education such as manufacturers. However, despite any improvement in clinician communication and training that may be effected, it may be desirable to automate device administration, maintenance, and upgrading to the extent possible in order to ensure that device instructions and data are appropriate to the situation.
A further limitation of the prior art relates to the management of multiple medical devices in a single patient. Advances in modern patient therapy and treatment have made it possible to implant a number of devices in a patient. For example, IMDs such as a defibrillator or a pacer, a neural implant, a drug pump, a separate physiologic monitor and various other IMDs may be implanted in a single patient. To successfully manage the operations and assess the performance of each device in a patient with multi-implants may require frequent update and monitoring of the devices.
Confirmation of basic device functioning following therapy events has been effected in the past using telephonic means. However, former methods of communication with medical devices did not provide for updating of software and firmware, or allow for operator training. In addition, former methods of communication with remote devices required the involvement of clinical personnel in the interpretation of data and prescription of treatment regimens or therapies. It would be desirable to remotely communicate information to and from implantable medical devices, and also provide for authentication of target device as well as confirmation of data integrity following the transmission of the patient data. Furthermore, it would be desirable to limit the degree to which human and particularly clinician involvement is required to effect the communication between an IMD and a remote resource.
Further, it may be preferred to have an operable communication between the various implants to provide a coordinated clinical therapy to the patient. Thus, there is a need to monitor the IMDs and the programmer on a regular, if not a continuous, basis to ensure optimal patient care. In the absence of other alternatives, this imposes a great burden on the patient if a hospital or clinic is the only center where the necessary upgrade, follow up, evaluation and adjustment of the IMDs could be made. Further, even if feasible, the situation would require the establishment of multiple service areas or clinic centers to support the burgeoning number of multi-implant patients worldwide. SUMMARY OF THE INVENTION The present invention provides a system for directing remote interrogation of
IMDs implanted in patients, even when the patients are in a location remote from the interrogation equipment. In one embodiment, the invention may be used to reduce or eliminate the need for a clinician or other person available to administer device interrogation. The invention may also create a means for gathering device data in advance of its actual review of a clinician. A remote interrogation will preferably allow clinicians to review data intermittently, even while an IMD is still accessing or adding to the same body of data as stored in memory on-board the IMD. In one embodiment of the invention, a computer remote to the host patient may initiate and subsequently store the contents of IMD device memory interrogated and transmitted to the remote computer. This data would then be available for examination in the future. For example, a referring physician could use the ability to examine the patient remotely as a consultation system.
A technology-based health care system that fully integrates the technical and social aspects of patient care and therapy will preferably flawlessly connect the client with care providers irrespective of separation distance or location of the participants.
Accordingly it is desirable to have a programmer unit that would connect to a centralized data source and repository. This may be termed, for example, a remote interrogator, or a remote data center. This remote data center will preferably provide access to an expert system allowing for downloading of upgrade data or other information to a local, i.e., IMD environment. Further, in one embodiment of the present invention, it is possible to enable the gathering of high resolution diagnostic/physiologic data, and to transfer information between the IMDs and a remote data center to dispense therapy and clinical care on real-time basis. Further, the data system contemplated by the present invention enables an efficient system for data storage, collection and processing to effect changes in control algorithms of the
IMDs and associated medical units to promote real-time therapy and clinical care. The proliferation of patients with multi-implant medical devices worldwide has made it imperative to provide remote services to the IMDs and timely clinical care to the patient. The use of programmers and related devices to communicate with the IMDs and provide various remote services has become an important aspect of patient care. In addition to the instant invention, the use of programmers may be implemented in a manner consistent with the co-pending applications detailed in the foregoing Cross Reference to Related Applications, and assigned to the assignee of the instant mvention. In light of the disclosures of these incorporated references, the present invention provides a vital system and method of delivering efficient therapy and clinical care to the patient.
In a representative embodiment of the instant invention, one or more IMDs, such as a pacemaker, defibrillator, drug pump, neurological stimulator, physiological signal recorder may be deployed in a patient. The IMD may be equipped with a radio frequency transmitter or receiver, or an alternate wireless communication telemetry technique or media which may travel through human tissue. For example, the IMD may contain a transmission device capable of transmitting through human tissue such as radio frequency telemetry, acoustic telemetry, or a transmission technique that uses patient tissue as a transmission medium. Alternately, an IMD may be deployed in a configuration where a transmission or receiving device is visible externally to the patient but is connected directly or via wires to the IMD. An external device, which may generally be termed an IMD Network Interface (IMDNI), may be positioned outside the patient, the IMDNI being equipped with a radio frequency or other communication means compatible with the communication media of the IMD or the IMD transmitter/receiver, which may be external to the IMD and may further be external to the patient. In an illustrative embodiment of the subject invention, IMDNI contains a radio frequency transmitter/receiver or similar radio frequency telemetry device. Communication may be effected between the IMD transmitter/receiver and the external IMDNI, e.g. via radio frequency. The IMDNI will be connected via a wireless or physical communication media, e.g. via modem and direct dial connection, with a data network, LAN, WAN, wireless, or infrared network. In an alternate embodiment of the subject invention, the IMDNI may have a direct connection or tunneled connection directly to the centralized computing resource. In yet another alternate embodiment of the subject invention, the system may be implemented as a data network that allows the IMDNI access to the computing center from many locations, for example providing for a IMDNI that is portable. Using the computing power of external computing devices, the monitoring of long-term disease progression (e.g. heart failure, hypertension, diabetes) can be improved. Furthermore, therapies may be adjusted with finer granularity and improved results, with reduced need for human intervention and reduced opportunity for clinician error. In addition to improved modeling of physiologic systems, the amount of historical data, particularly patient-specific historical data used as input to control systems can be virtually unlimited when it is stored externally to the patient. Furthermore, a more thorough comparison can be made between patients with similar diseases as data and therapy direction are centralized, which may be expected to result in gains to the body of medical knowledge and treatment efficacy. Data from other medical systems, either implanted or external, such as etiological databases, can be incorporated easily into the control system. Other anonymous patient experiences or treatment data may be more quickly incorporated into a subject patient's IMD regime than might be possible with existing systems of IMD programming or upgrading. In addition, a subject patient's own historical treatment parameters and corresponding outcomes may be used in making IMD programming and other treatment decisions. The instant invention provides IMDs with access to virtually unlimited computing power as part of their data collection and therapy calculation processes. In an alternate embodiment of the present mvention, the IMD may be used by an external computing device as a data collection agent, and as an agent to implement changes to a treatment regimen based on a complex dynamical or stochastic physiological model. Rather than continuously increasing the processing power of IMDs, the present invention provides a link with external computing power, which is more easily upgraded. In addition, control system algorithms based on current knowledge about physiologic systems could be more easily updated using a centralized powerful processor, rather than individually updating the firmware or software of thousands of deployed IMDs.
When multiple IMDs are deployed within a single patient, the data and therapy from these IMDs may be more easily and efficiently orchestrated, thus further improving treatment efficacy and convenience to the patient and clinician, and in some cases judiciously limiting clinician involvement. In addition, high resolution or finely grained data may be collected and stored from a vast number of subject IMDs. This finely grained patient data may be expected to prove valuable in defining and modifying an individual patient's treatment regimen as implemented by an IMD. In addition, this high-resolution data may be analyzed on a mass scale, providing opportunities for improvement of existing physiologic models. This data may serve, for example, to validate physiologic models being employed, or may suggest refinement of these models based on numerous patient outcomes.
This refinement of therapy and diagnostic algorithms or models may further be refined in conjunction with external medical devices as well. According to the present invention, IMD management and manipulation will be more efficient and efficacious. For example, an embodiment of the present invention permits the use of complex control systems to manage therapy of implantable medical devices. In addition, the invention permits the orchestration of the data collection and therapy functions of IMDs, particularly the functions of multiple IMDs implanted in one patient. In addition, an embodiment of the present invention permits of centralized therapy prescription, and provides the ability to compare disease states, diagnostic data and therapy prescription across patients with fine granularity. The ability to update control system software and hardware at a central location is also provided, as well as the ability to upgrade the firmware or software in distributed deployed IMDs from one central location.
A communications system according to the present invention provides the ability to have high-power computing systems interact with implanted medical devices, thus providing the ability to use complex control algorithms and models in implanted medical devices. In addition, even with relatively simple modeling, or in stochastic models, relatively large amounts of historical data from a single or multiple medical devices may be brought to bear for predictive purposes in evaluating alternate therapy and IMD instruction prescriptions. The present invention provides a system that establishes an external communications device and data network as a 'data bus' for extending the processing power of deployed IMDs, while minimizing host patient and clinician inconvenience.
The present mvention may be effected, in part, by the provision of an IMDNI device, which may be a standalone device or a computer peripheral device, that is capable of connecting an IMD, or simply data telemetrically received from an IMD, to a network or other data communication link. While the interface between a computer data link and an implanted medical device is referred to generally herein as a "Network Interface", or the like, it will be appreciated to those skilled in the art that the interface may serve as an interface to a variety of data communications systems, including not only networks, but also, without limitation, direct dial-up connections, dedicated lines, direct satellite links, and other non-network data communications connections.
In a preferred embodiment of the subject invention, a host patient, i.e., a patient having an IMD implanted within, presents themselves to a IMD network interface device, or IMDNI. This IMDNI will preferably have the capability of communicating with the IMD via wireless means, such as by radio transmissions. In one embodiment of the subject invention, the IMDNI may be placed, for example, in a patient's home, or may be available for use by several patients in a treatment facility such as a hospital, nursing home, or ambulatory care center.
In one embodiment of the mvention, data can be interrogated, with the aid of a remote interrogator device, by an IMDNI in an emergency room and then uploaded to an information network to which a remote interrogator is connected. This information network may be according to any network protocol, for example, TCP/IP over the Internet. The uploading to a central interrogation computer may also be effected over a direct dial-up connection or a dedicated line. Upon uploading of the data, a medical professional or other clinician may be alerted to the fact the data has been uploaded. This clinician may then view the data. A patient could also interrogate his or her device at home and upload it for a medical professional or clinician to view later. Various scenarios according to the invention may provide convenient monitoring of IMD functioning to a host patient or clinician. For example, a patient may effect a test of their IMD with a device tests such as an exercise or stress test in a more natural or real life scenario that may provide more reliable or accurate results than a clinical evaluation, in addition to providing increased convenience to the patient and reducing the need for clinician or other professional attention.
In this embodiment of the invention, for example, a host patient may effect a dial-up connection to a remote interrogator following an afternoon walk in their neighborhood or on a treadmill in their home. In addition to evaluation of device function during routine situations, according to this embodiment of the present invention, a home monitoring instrument may be provided to a host patient allowing the patient to send data, i.e., to effect remote interrogation, if, for example, they have a subjective belief that they are symptomatic. For example, a host patient of a cardioverter defibrillator IMD may effect remote interrogation if they believe they have suffered an arrhythmia event. The data resulting from the remote interrogation may then be made remotely accessible for evaluation by a pacing system expert. In a preferred embodiment of the subject invention, IMD f nction data and physiologic data of the host patient is made available nearly instantaneously to a clinician capable of evaluating the device function, physiologic event or data, or therapy administered by the target IMD.
In a preferred embodiment, the remote interrogator of the present invention is implemented as a software application which may be run on a server or central computer accessible via a network or direct connection by the IMDNI device. In an alternate embodiment, the IMDNI may be implemented as a software client which may run on a computer remotely from the interrogator server. Preferably, the remote interrogator program or device is capable of autonomously and dynamically determining the model of an IMD, for example, according to manufacturer, type, and model number, as well as the specific serial number of a particular device. When an IMD is within communication range of an IMDNI, the remote interrogator of the present invention is also preferably capable of configuring a deployed IMD, or commanding the IMDNI to retrieve data from the IMD. In a preferred embodiment, an interaction between a deployed IMD and the remote interrogator may take place within a discrete session. This session may encompass interrogation of one or more IMDs deployed in a single patient. In a representative embodiment, a session according to the present mvention may proceed according to the following scenario. In order to begin an interrogation session, a host patient will typically present to an IMDNI. For example, the patient may place themselves in the vicinity of the IMDNI within range of the telemetry capacities of the IMDNI. This may take place at home in the case of a In Home Monitor (IHM) or at a medical facility such as an Emergency Room, Follow-up Clinic or Operating Room. At the initiation of a session, it will be preferable to configure the target IMD for optimal operation for remote interrogation. For example, the IMDNI may be programmed to issue a command to the target IMD to "Cancel Magnet", "Resume Therapy," or another command to enter a mode consistent with the interrogation process. Either prior to or after the establishment of a telemetry or other communication link with the target IMD, the IMDNI Operator will effect a communications link between the IMDNI and the remote interrogation computer. This IMDNI Operator may be a human attendant or technician, but preferably will be an automated module of the IMDNI firmware or software, or may be implemented as a software application on a general purpose computer connected to the IMDNI. Alternatively, the remote interrogator computer may lead a human or automated
IMDNI through the steps of establishing a telemetry interface between the IMD and IMDNI; with the IMDNI in turn notifying the remote interrogator when a telemetry connection has been established. Communication with the remote interrogation server may be established via a network connection, such as a LAN or WAN. In this embodiment of the present invention in which the IMDNI is preferably attended by an operator, the operator may be the host patient of the target IMD, or it may be attendant personnel at a clinical setting. In either case, the operator may connect the IMDNI to a suitable network connection, if a network connection is not already in place. For example, a direct dial-up connection may be established in this manner by physically connecting the IMDNI into a telephone connection jack such as a RJ-11 analog jack. The operator at some point would turn the IMDNI on and cause the IMDNI system to dial a pre-configured telephone number. Alternately, other, more continuous types of network connections may also be established.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 depicts a general network architecture diagram of a system embodying the subject invention.
Figure 2 depicts an implementation of the system of Figure 1 using specific hardware components.
Figure 3 depicts an alternate implementation of the system depicted in Figure 1, including additional hardware devices.
Figure 4 is an architectural drawing of an embodiment of the subject invention showing internal device architecture.
DETAILED DESCRIPTION OF THE DRAWINGS Figure 1 depicts a general architectural view of a remote interrogation system according to an embodiment of the present invention. An IMD polling and interrogation system 110 is provided. IMD 112 has been deployed in a patient, for example, a patient at a location remote from remote interrogator connected to or within information network 114. The IMD 112 may be one of a number of existing or to be developed IMDs, for example, a pacemaker, defibrillator, drug pump, neurological stimulator, physiological signal recorder, oxygen sensor, or the like. A device external to the patient is provided which may be termed an IMD Network Interface, or IMDNI 116. This IMDNI 116 may communicate with the IMD 112 via, e.g., radio frequency, as discussed above. The IMDNI 116 may also communicate with a data network 114 via modem, LAN, WAN, wireless or infrared means according to network connections 118 and 120. This data network 114 is preferably able to communicate via a computer network or other suitable data communications connection with a central computer within information network 1 14. While in Figure 1, a single IMD 112 is depicted, the subject invention permits of use with multiple IMDs deployed in a single patient, each making separate transmissions and receiving separate instructions from IMDNI 116. In an alternate embodiment of the subject invention, multiple IMDs deployed in a single patient are all linked to a single telemetry device implanted in a patient. This telemetry device may be separate from or incorporated into one of the IMDs deployed in a patient.
Returning to the single IMD embodiment depicted in Figure 1, IMD 112 is equipped with or linked to a transmission and receiving device such as a radio frequency telemetry device, also preferably implanted in a patient. The information network 114 computing center or central computer preferably has sufficient computing power and storage capability to collect and process large amounts of physiological data using complex control systems. The patient is placed or places himself or herself in proximity to IMDNI 116. For example, IMDNI 116 may be placed in a patient's home, at their bedside perhaps, or may be placed in a community center, clinical office setting, nursing home, or other care facility. IMDNI 116 may also be embodied in a portable device that may be carried by the patient while outside the home or traveling. IMDNI 116, like IMD 112, contains or is linked to a communications media transmitter/receiver compatible with the type incorporated into or linked to
IMD 112. In an illustrative embodiment of the subject invention, IMDNI 116 contains a radio frequency transmitter/receiver or similar radio frequency telemetry device establishing radio frequency link 118.
Figure 2 depicts an implementation of the system of Figure 1 using specific hardware components. As shown, information network 114 includes remote interrogator computer 220. Remote interrogator 220 will preferably be possessed of appreciably more computing power than possible with an IMD 112, in terms of processor speed, RAM available, and other data storage. Remote interrogator computer 220 is large scale in comparison to such processors that are available for incorporation into an IMD 112. For example, some commercially-available personal computers may contain sufficient computing power to operate as a server capable of carrying out many IMD 112 diagnostic, programming, and data storage tasks. In a preferred embodiment of the subject invention, however, remote interrogator 220 will be a back end data server, or a high end data server. Such relatively high-powered computing devices are better suited to calculations involving nonlinear systems and models such as those being developed to model physiologic systems. Regardless of which computing device is used, in accordance with the present invention, the computing device will be configured as a server capable of communicating directly or indirectly with IMDNI 116. The computer 220 will preferably have sufficient storage, either internal to the computer or linked to the computer, for the storage of massive amounts of historical patient data from, for example, a particular patient having an IMD 112 in communication with computer 220, and/or subject data from relevant physiologic studies or from cohort groups having similar medical conditions and/or deployed IMDs. For example, as depicted in Figure 2, remote interrogation computer 220 is linked to or contains data storage element 222. Data storage element 222 may contain any suitable means of data storage, including but not limited to hard drive, or another readable/writable magnetic or optical storage. In a preferred embodiment of the subject invention, data storage element 222 has a redundant array of disks such as a redundant array of inexpensive disks (RAID) system. Security and integrity of the patient information and IMD interface operation will preferably be closely guarded for at least the following reasons: First, patient physiologic data detected by a deployed IMD 112 will be transmitted via IMDNI 116 to computer 220 for purposes of analysis of this data, and treatment regimens and/or IMD 112 instructions, firmware, or software may be changed on the basis of this information. Accordingly, integrity of transmitted data and instructions will preferably be maintained so as to avoid adverse patient outcomes or patient outcomes that do not take full advantage of the subject invention. In addition, patient information that may be linked to an identifiable individual is typically regarded as confidential. Accordingly, encryption or tunneling will preferably be provided to ensure patient confidentiality, particularly when transmissions between IMDNI 116 and computer 220 takes place though media other than a dedicated line/direct dial-up connection, such as a packet-based network technology over a public network or internetwork. For example, if the transmissions are routed over the Internet using TCP/IP, encryption will preferably be used. As an alternative to encryption, a proprietary data exchange format/interface that is kept secret may be used in communications between IMD 112 and IMDNI 116. However, even with secure dedicated lines or a secret data format, digital signatures will preferably be used to detect corruption of data. Additional implementations of security systems may also be utilized in accordance with the subject invention, including biometric security apparatus and methods to detect inalterable physical characteristics of persons attempting to access the patient data in order to authenticate the would-be user of the system.
Security measures such as the foregoing will preferably be used to authenticate the IMDNI 116 and IMD 112, as well as persons attempting to access patient data, including a host patient. A preferred embodiment of the subject invention utilizes digital signatures and encryption of the patient information and IMD 112 instructions being transmitted according to the present invention. Encryption of patient information will serve to protect patient confidentiality. Each transmission of patient data will preferably have a digital signature that can be checked against the transmission payload to ensure that patient data and IMD 112 instructions were not corrupted during transmission.
Examples of encryption/digital signature schemes that should prove sufficient for suitable encryption of patient information and digital signatures include PGP, the RSA public key infrastructure scheme, or other consumer-level or higher, prime number based encryption signature scheme. Biometric data used to authenticate and verify accessors of the data may include retina scans, iris scans, fingerprint scans, vein print scans, voiceprints, characteristics, facial geometry/facial recognition according to facial nodal points, or hand geometry scans. In addition to the above security implementations, a preferred embodiment of the subject invention incorporates firewall and/or proxy server technology, as indicated in Figure 2 at firewalls 226 and 228. Such security measures not only protect patient data stored in data storage element 222 from access by unauthorized persons, but also protect IMDNI 116 and IMD 112 from improper snooping and/or improper instruction from negligent or unscrupulous persons that may have access to data network 230. In addition to communicating with IMD 1 12 as discussed above, IMDNI 116 may communicate with a peripheral physiological data gathering device 232, which may for example be external to the host patient having implanted IMD 1 12. IMDNI 116 may also communicate with additional devices as detailed in Figure 3, central information network 114 via a number of network schemes or connections, with regard to any of the OSI layers. The network is depicted generally at network cloud 230. For example, communication may be effected by way of a TCP/IP connection, particularly one using the Internet, as well as a PSTN, DSL, ISDN, Cable Modem, LAN, WAN, MAN, direct dial-up connection, a dedicated line, or a dedicated terminal connection to a mainframe. Various persons 118 including clinicians or the patient having IMD 112 installed may access the patient's data from information network 114, as described herein. This reduces the need for on-site clinical visits by the patient.
Transmissions between an IMD 112 and IMDNI 116 or between peripheral physiological data gatherer 232, or other peripheral devices will also preferably be protected from transmission errors using similar encryption, authentication, and verification techniques to those discussed above, and or wireless communication enhancement techniques such as wireless modulation or another suitable wide-frequency spectra technique. Preferably, encryption and/or authentication will be effected end-to-end, i.e., covering the entire transmission from IMD 112 to computer 220 or from computer 220 to IMD 112, rather than effecting one encryption/verification scheme between IMD 112 and IMDNI 116, and a different scheme between IMDNI 116 and computer 220. As an alternative to, or in addition to the above authentication scheme, radio frequency pulse coding, spread spectrum, direct sequence, time-hopping, frequency hopping, a hybrid spread spectrum technique, or other wireless modulation techniques may be employed in order to reduce interference between IMD 112 and other IMD or other wireless devices, and to generally offer improved accuracy, reliability, and security to transmissions between IMD 112 and IMDNI 116, may be used to avoid cross-talk or confusion among IMDs and/or IMDNIs in proximity to each other. For example, radio coding may be implemented to avoid transmission errors or device confusion between neighboring IMD 112 patients utilizing a device implementing aspects of the present invention in a managed-care setting. Preferably, a data network is provided that allows the external communications device, or IMDNI 116, access to the computing center 220 from one of many possible locations. This provides portability to the administration of the IMDNI 116 and enhancement patient lifestyle. Upon establishment of a network connection, or direct dial-up connection, a communications link is established over which the IMDNI 116 may establish a connection with the remote interrogator computer 220. The initial communication may focus on authentication of the IMDNI 116. This will preferably include verification that the IMDNI 116 is certified for interrogating IMDs, i.e., a verification process has established that the software and hardware revisions are current, and that the authentication information uniquely identifies a specific known IMDNI 116.
Further considering the steps in a representative embodiment of the invention in which the IMDNI is attended by an operator, the remote interrogator 220 may next instruct the IMDNI Operator such as a human user how to configure the telemetry mterface 118 between IMDNI 116 and IMD 112. This would typically be specific for the type of IMD 112 being interrogated and might involve, for example, placing a programming head or wand near the IMD 112, or just positioning the patient and IMDNI 1 16 in proximity. The IMDNI 116 may then notify the remote interrogator computer 220 that a telemetry connection has been established. Upon establishment of a telemetry interface, preferably remote interrogator
220 selects a proper device agent software application or module to interrogate the specific device 112. This software application may be accessed from, for example, a separate device agent software server 224, or may be accessed directly by remote interrogator computer 220 from data store 222. In a representative embodiment of the invention, a device agent software module is selected to interface with a particular type or model of IMD 112. In an embodiment of the subject invention in which the IMDNI 116 is configured to dynamically identify an IMD 112 presented to it for remote interrogation, preferably an initial IMD 112 identification stage precedes the selection of device agent module. In an embodiment of the present invention configured or adapted for use with an in-home monitor device, preferably the IMDNI is pre-configured to work only with the specific device(s) implanted in an individual host patient of the residence.
Upon execution of the applicable software module, for example the device agent corresponding to the IMD 112 presented to the IMDNI 116, the remote interrogator computer 220 may retrieve certain pertinent data from the IMD 112, including physiologic data regarding the host patient stored in IMD 112 memory, stored power remaining, amount of drug remaining within the device, or hardware, software, or firmware version information, or other device status information.
Upon completion of the data retrieval operation, the remote interrogator 220 may signal the completion of the operation to IMDNI 116. Preferably, the remote interrogator 220 will then close the connection with IMDNI 116, for example after a disconnect request to the IMDNI 116, for example, as part of the implementation of a symmetric release to avoid possible loss of data. The IMDNI 116 may then terminate the telemetry or other wireless connection with the IMD 112. This may involve the issuance of instructions to a human IMDNI Operator, if applicable, to effect the termination in a certain manner, for example, by removing the IMDNI 116 from proximity to the host patient. Preferably, the IMDNI 116 will not terminate communication with the IMD 112 until after the connection with the remote interrogator 220 is released. Figure 3 depicts an alternate implementation of the system depicted in Figure
1, including additional hardware devices. As shown in greater detail in Figure 3, once the data is collected from the IMDNI 116, notifications or confirmations may be generated by remote interrogator 220. These notifications may in desired cases be made available to remote data devices 310, such as a remote computer 312, fax machine 314, cellular telephone 316, or other data device which may be operated by or for individuals or entities interested in the target IMD 112 operation or host patient data. The data may also be provided to remote patient in-home personal computer 318. Preferably, these notifications may be accompanied by relevant data, and are made only to devices or individuals that have been properly authenticated as having permission to view the patient data. In addition, and particularly when provided to a remote computer 312 or 318, this data is preferably encrypted or digitally signed to preserve its confidentiality and for confirmation of data integrity. Various data communications methods may be suitable for transmission of the target device and host patient data to a remote computer, including an SMTP e-mail, FTP, or TCP/IP. In one embodiment of the present invention for example, properly authenticated interested parties may access the patient or device data, the data residing on a server such as the remote interrogator, via TCP/IP protocol using a web browser. It is also preferable that confirmation that the data has been retrieved successfully by the remote interrogator 220, or has been transmitted to a particular remote user such as a physician using remote computer 310, is transmitted to the site of collection and displayed on the IMDNI 116, or on a computer or other data device such as patient home computer 318. A confirmation that a remote clinician, for example, a clinician that is located somewhere other than the site of the IMDNI data collection point, or from the remote interrogator 220, has accessed the data via remote computer 310, may be transmitted to the site of collection 116 or to another location or device 310 or 318. This confirmation may be effected, for example, by a reply e-mail from a clinician that has received an SMTP message from remote interrogator 220, indicating that the data has been received or reviewed.
The present invention admits of various revenue-creating, or treatment administration or business applications. For example, prior to an appointment with a clinician, a pre-appointment interrogation may be effected using the system outlined above in order that the clinician may have reviewed or analyzed the relevant host patient or target device data prior to an in-person appointment by a host patient. In addition, a follow-up interrogation of a target device a certain prescribed time following an in-person appointment or other event may be provided for and automatically scheduled for execution by a IMDNI 116. For example, the IMDNI
116 may be programmed to poll for or otherwise attempt to establish telemetry or other data communication with a target device 112 at a certain time or interval; the success of the attempt possibly being contingent on the host patient being in proximity to the IMDNI 116 at the specified time, or on the connection of the IMDNI 116 being physically or otherwise connected to a data communications means such as a wireless connection or physical connection such as a RJ-11 phone jack. The present invention also admits of use during or following symptomatic events experienced by a host patient, providing for interrogation analysis and results. In any event, more convenient and/or more frequent patient monitoring and analysis is provided by the present invention, with a reduced reliance on in-person or on-site clinical visits by the host patient. In one embodiment of the present invention, the remote interrogation system described herein may be provided to a host patient or to a clinician or clinical entity on a subscription basis, or on a fee per use or per data access basis.
In operation, the deployed IMD 1 12 collects physiological data from the host patient via electrical, mechanical or chemical sensors, according to the type of IMD 112 deployed in the host patient. Some of this data may be used locally, i.e., processed and analyzed internally to the IMD 112 itself, to modify therapy or treatment on a 'real-time' basis. In addition, IMDNI 116 may access and store data from an IMD programmer 320, interface medical unit 322, or in-home monitor 324. Regardless of whether the physiological data from the host patient is used to modify therapy on this self-contained basis, the patient data will preferably be buffered, queued, or spooled in the IMD 112 until such time as the device is polled or "interrogated" by remote interrogator 220 using the IMDNI 116. During this transaction, the IMDNI 116 may also pass instructions received from the remote interrogator 220 to the IMD 112. IMDNI 116 may contact the computing center or central remote interrogator 220 and transmit the physiologic data uploaded from IMD 112 to IMDNI 116. The powerful computer(s) at the computing center 220 may store and/or process the data, perhaps combining it with historical data of the same type from the same device, or perhaps with data from other implanted and medical devices. For example, the physiologic data may be combined with anonymous data from other demographic or clinical groups consisting of subjects which may have data relevant or generalizable to host patient 114. For example, comparisons of the data collected may be made with data from other patients with similar disease states, and therapy solutions constructed and compared. The computing center may then transfer instructions on modifications to therapy and data collection to the IMDNI 116. At the next opportunity for communications, the IMDNI 116 transfers the instructions to the IMD 112 and may also collect an additional batch of data buffered in the IMD 112. This opportunity for communication between IMDNI 116 and IMD 112 may not be immediately present. For example, IMD 112 within a host patient may be located away from IMDNI 1 16 temporarily, if the host patient has left their house or clinical setting where the IMDNI
116 is kept. An alternate barrier to IMDNI 116 to IMD 112 communication may be a poor environment for the communication media employed between the IMD 112 and the IMDNI 116.
Data may also be held at the remote interrogator 220 or within IMDNI 116, for example, if the IMDNI 116 is carried by host patient as a portable device, and an analog connection for a modem or suitable network connection may not be available. In a preferred embodiment of the subject invention, communication system 110 will operate asynchronously, permitting for the possibility for breaks in the continuous and real-time communications and/or processing of the three subsystems (IMD 112, IMDNI 116, and remote interrogator 220. However, alternate embodiments of the invention are also possible, including synchronous, "real-time" control of the target IMD 112. This alternate "real-time" embodiment of the system 110 may be enhanced upon the establishment of more ubiquitous and robust communications systems or links. Initially the system would act in an asynchronous manner, where precise timing of data transfer and therapy changes is not critical. As the device-instrument and network communications become more ubiquitous and less reliant on specific hardware (e.g. RF head, network cables), the control loop could become more time- dependent. Figure 4 is an architectural drawing of an embodiment of the subject invention showing internal device architecture. As depicted in Figure 4, IMD 112 effects the collection of high resolution physiological data; and provides for its temporary storage or buffering, for example in storage device 410. This storage device is preferably a RAM module of a type suitable for implantation in IMDs. Prior to storage in storage device 410, IMD processor 412 will preferably compress the physiologic data collected by physiologic sensor 414. IMD processor 412, in addition to processing the reception and storage of physiologic data, also preferably effects implementation of IMD 112 therapy, through treatment administration device 416. For example, and depending on the type of IMD 112 in which the subject invention is implemented, processor 412 may control the amount or frequency of electrical stimuli or drug delivered by treatment administration device 416. This control may be based on instructions originating from remote interrogator 220. Figure 4 also depicts in greater detail the architecture of IMDNI 116 of Figure 1. As shown in Figure 4, IMDNI 1 16 contains a transmitter/receiver 420, a processor 422, storage device 424, and communication device 426. Communication device 426 may be, for example, a modem or network interface card. It may be seen in Figure 4 that IMDNI 116 contains architecture components similar to those seen in a computer, and in an alternate embodiment of the subject invention, the communication system 110 of Figures 1 -4 may be deployed with IMDNI 116 implemented as a computer with a peripheral device that may communicate with IMD 112. For example, IMDNI may be implemented together with a peripheral device to patient computer 318 of Figure 3.
As shown in Figure 4, communications between IMDNI 116 and remote interrogator 220 may be effected either through a network 230, such as a LAN or the Internet, or communications may be effected through a direct dial-up or dedicated line, or through a terminal connection to a mainframe. These possible implementations are indicated generally by communications link 430. Typically, these connections may be considered alternatives, or both communications links, i.e., relatively direct link 430 and link through network 230 may be implemented in order to provide a backup communications system to the link used as the primary communication method. In a preferred embodiment of the subject invention depicted in Figure 4, remote interrogator 220 creates an instruction file for IMDNI 116 and/or for IMD 112. This file may consist largely of instructions for the IMD 112 affiliated with an IMDNI 116. Remote interrogator 220 may then contact IMDNI 116 to initiate transfer. Preferably, this method of contact will correspond to the method of communication from IMDNI 116 to remote interrogator 220, although an alternate method may be used, particularly if a first preferred method proves unsuccessful. If communication with IMDNI 1 16 is possible, suitable instructions or information may be forwarded to IMDNI 1 16 for immediate or eventual communication to IMD 1 12.
While the instant invention has been described primarily with a single IMD 112 corresponding to a single IMDNI 116 and to a single central computer 220, alternative embodiments of the present invention are possible. For example, several
IMDs 112, each with a separate identifying code or number, may utilize a single IMDNI 116. These several IMDs 112 sharing a IMDNI 116 may be deployed within a single patient, or the several IMDs 112 sharing a IMDNI 116 may be deployed in two or more separate patients, where each patient has reasonable access to the IMDNI 116 directly or to communications equipment which may send information to and receive information from IMDNI 116. While in an illustrative embodiment, several IMDNIs 116 share a remote interrogator 220, alternative embodiments may have a single IMDNI 116 communicating with distributed or parallel remote interrogators 220, in addition to or in place of remote interrogator 220. In addition, an instruction regimen for a target IMD 112 may not be based solely on treatment considerations arising from patient data or from predictive modeling. In addition, an instruction regimen may contain firmware or software upgrades to target IMD 112 which are prescribed generally for all host patients of a particular IMD 112 model or type. Upon establishment of contact between IMDNI 116 and IMD 112, an instruction regimen may be pushed or generally transmitted to IMDNI 116. IMDNI
116 or equivalent may then store the results of processing or instruction carried out by remote interrogator 220, for example, as dictated by device agent server 224. The IMD 112 instruction regimen prescribed by central computer 116 may be stored within IMDNI 116 indefinitely or for a fixed period of time prior to expiration. At the next opportunity for communication between IMDNI 116 and IMD 112, IMDNI 116 provides new therapy programming, as well as new instructions for data collection if necessary. In a preferred embodiment of the subject invention, if an instruction regimen has been received by IMDNI 116 for communication to target IMD 112, IMDNI 116 will periodically poll IMD 112 in attempts to establish a communication link, such as a wireless link. In an alternate embodiment of the subject invention,
IMDNI 116 may have a display feature, which could be for example an LCD display or a simple indicator light indicating that an instruction regimen has been received for forwarding from central computer 220. A human user, for example, host patient of IMD 1 12 may press a button or otherwise initiate the process of communication between IMDNI 116 and target IMD 112. While IMDNI 116 is portrayed primarily as a self-contained or stand-alone unit, it will be appreciated that IMDNI 116 may also be implemented as a peripheral transmitter receiver capable of wireless communication with IMD 112, and also in communication with a computer such as patient home computer 318, such as a personal computer such as a laptop or portable computer. Computer 318 may also be a terminal of a remote computer 220. It will be appreciated that in the event that IMDNI 116 is implemented as a peripheral and terminal, some of the components of IMDNI 116, such as its storage component, may be implemented on a central computer 220 or storage device 222 rather than in the terminal implementing IMDNI 116. For example, the functions of IMDNI 116 of Figure 2 may be implemented in software resident on routing computer 318. Communications interfaces of computer 318 when linked with IMDNI 116 may include a modem, network card, direct connection, or terminal connection. In this embodiment, preferably all data communication, security and message authentication and integrity confirmation as discussed above with regard to IMDNI 116 will be implemented on local computer 318. Communication between IMDNI 116, and central computer 220 may be implemented via network 230 or via direct connection.
If IMDNI 116 is implemented on a computer such as a PC 318 of Figure 3 with an IMDNI 116 transmitter/receiver peripheral device, a suitable pop-up message on the PC monitor may indicate a pending IMD 112 instruction or request, or an indicator on a display of the peripheral transmitter/receiver device 116 may indicate a pending instruction as above.
If an IMD 112 instruction regimen has expired prior to establishment of contact with the target IMD 112, IMDNI 116 may send an error message identifying the IMD 112 and/or instruction regimen by a suitable code. Upon reception of an error in instruction regimen transmission, central computer 220 may be programmed to carry out suitable updating of an instruction regimen, or an error message may be output to remote devices 310, a human operator or clinician for direct intervention by voice telephony or direct contact by mobile clinical personnel, for example.
Although the invention is described with reference to particular embodiments, it will be understood to those skilled in the art that this embodiment is merely illustrative of the application of the principles of the invention. Numerous modifications may be made therein and other arrangements may be devised without departing from the spirit and scope of the invention.

Claims

CLAIMSWhat is claimed is:
1. A computerized method of obtaining and distributing data from one or more IMDs deployed in one or more patients, said IMDs having firmware or software, comprising the steps of: transmitting via a network communication link IMD-accessible data gathered from at least one of the IMDs to a external device capable of communicating with a computing resource external to any patient; routing the IMD data to a computer; determining instructions comprising an IMD treatment regimen based on data gathered by or stored in the IMD; and transmitting via the network communication link the instructions to the appropriate IMD which may be executed by the IMD in accordance with its firmware or software.
2. The computerized method of claim 1, wherein the IMD-accessible data comprises physiologic data from the patient.
3. The computerized method of claim 1, wherein the IMD-accessible data comprises device information.
4. The computerized method of claim 3, wherein the device information includes hardware, firmware, or software identification information.
5. The method of claim 1 , wherein the network communication link comprises a radio frequency link.
6. The method of claim 2, wherein the network communication link comprises a hybrid link.
7. The method of claim 3 wherein the hybrid link comprises a radio frequency link from an IMD to a network interface, and a secondary network link from the network interface to the computer.
8. The method of claim 7 wherein the secondary network link is a direct dial up connection.
9. The method of claim 7 wherein the secondary network link is an area network.
10. The method of claim 9 wherein the area network is a LAN.
11. The method of claim 9 wherein the area network is a WAN.
12. The method of claim 7, wherein the secondary network communication link comprises an asynchronous link.
13. The method of claim 7, wherein the secondary network communications link comprises a synchronous link.
14. The system of claim 1, wherein the one or more IMDs comprises one or more of a pacemaker, a PCD pacemaker/cardioverter/defibrillator, an oxygen sensing device, a nerve stimulator, a muscle stimulator, a drug pump, or an implantable monitoring device.
15. The computerized method of claim 1 , comprising the further step of transmitting from the computer to one or more IMDs an upgrade to the IMD firmware or software.
16. The computerized method of claim 1, further comprising the step of distributing the IMD data from the computer to one or more remote data interface devices.
17. The computerized method of claim 16 wherein the remote data interface device comprises one or more network computers, facsimile machine, telephone, voice mail systems, cellular devices, pagers, PDAs, printers, or broadcast reception devices.
18. A computerized information network system linking one or more IMDs deployed in one or more patients to a computer via a data communication network, said network comprising: a first computer accessible by the network, said central computer capable of storing patient data recorded by an IMD; at least one network interface capable of wireless communication with at least one IMD deployed in a patient, said network interface being capable of communication with the network.
19. The computerized network of claim 18, wherein the network comprises a direct link between the at least one network interface and the computer.
20. The computerized network of claim 18, wherein the first computer comprises a supercomputer.
21. The computerized network of claim 18, wherein the first computer comprises a multi-processor workstation.
22. The computerized network of claim 18, wherein the first computer comprises a networked or parallel cluster of computers.
23. The computerized network of claim 18, wherein the data communication is asynchronous.
24. The computerized network of claim 18, where the data communication is synchronous.
25. The computerized network of claim 18, further comprising a second computer on which device instructions or device operation and control software may be accessed by the first computer.
PCT/US2000/034486 1999-12-24 2000-12-19 Information network interrogation of an implanted device WO2001047597A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP00986575A EP1244382A2 (en) 1999-12-24 2000-12-19 Information network interrogation of an implanted device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17306499P 1999-12-24 1999-12-24
US60/173,064 1999-12-24

Publications (3)

Publication Number Publication Date
WO2001047597A2 true WO2001047597A2 (en) 2001-07-05
WO2001047597A3 WO2001047597A3 (en) 2001-11-15
WO2001047597B1 WO2001047597B1 (en) 2001-12-27

Family

ID=22630381

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/034486 WO2001047597A2 (en) 1999-12-24 2000-12-19 Information network interrogation of an implanted device

Country Status (3)

Country Link
US (1) US6480745B2 (en)
EP (1) EP1244382A2 (en)
WO (1) WO2001047597A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006107A1 (en) * 2001-07-10 2003-01-23 Medtronic, Inc. Custom manufactoring of implantable medical devices
WO2003024322A1 (en) * 2001-09-19 2003-03-27 Menard Raymond J Personal medical device communication system and method
US7088233B2 (en) 1998-10-23 2006-08-08 Royal Thoughts, Llc Personal medical device communication system and method
US7103344B2 (en) 2000-06-08 2006-09-05 Menard Raymond J Device with passive receiver
US7138902B2 (en) 1998-10-23 2006-11-21 Royal Thoughts, Llc Personal medical device communication system and method
EP2093666A1 (en) * 2008-02-19 2009-08-26 Codman Neuro Sciences Sàrl Implant revision recognition by exchanging the revision data during transmission
WO2010111489A3 (en) * 2009-03-27 2010-11-18 LifeWatch Corp. Methods and apparatus for processing physiological data acquired from an ambulatory physiological monitoring unit
US9220430B2 (en) 2013-01-07 2015-12-29 Alivecor, Inc. Methods and systems for electrode placement
US9247911B2 (en) 2013-07-10 2016-02-02 Alivecor, Inc. Devices and methods for real-time denoising of electrocardiograms
US9254092B2 (en) 2013-03-15 2016-02-09 Alivecor, Inc. Systems and methods for processing and analyzing medical data
US9254095B2 (en) 2012-11-08 2016-02-09 Alivecor Electrocardiogram signal detection
US9351654B2 (en) 2010-06-08 2016-05-31 Alivecor, Inc. Two electrode apparatus and methods for twelve lead ECG
US9420956B2 (en) 2013-12-12 2016-08-23 Alivecor, Inc. Methods and systems for arrhythmia tracking and scoring
US9649042B2 (en) 2010-06-08 2017-05-16 Alivecor, Inc. Heart monitoring system usable with a smartphone or computer
US9839363B2 (en) 2015-05-13 2017-12-12 Alivecor, Inc. Discordance monitoring

Families Citing this family (358)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060064135A1 (en) * 1997-10-14 2006-03-23 Transoma Medical, Inc. Implantable pressure sensor with pacing capability
US20020120200A1 (en) * 1997-10-14 2002-08-29 Brian Brockway Devices, systems and methods for endocardial pressure measurement
US8265907B2 (en) 1999-03-03 2012-09-11 Card Guard Scientific Survival Ltd. System and a method for physiological monitoring
US6270457B1 (en) 1999-06-03 2001-08-07 Cardiac Intelligence Corp. System and method for automated collection and analysis of regularly retrieved patient information for remote patient care
US7134996B2 (en) * 1999-06-03 2006-11-14 Cardiac Intelligence Corporation System and method for collection and analysis of patient information for automated remote patient care
CA2314517A1 (en) 1999-07-26 2001-01-26 Gust H. Bardy System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
US6221011B1 (en) * 1999-07-26 2001-04-24 Cardiac Intelligence Corporation System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
CA2314513A1 (en) 1999-07-26 2001-01-26 Gust H. Bardy System and method for providing normalized voice feedback from an individual patient in an automated collection and analysis patient care system
US6336903B1 (en) 1999-11-16 2002-01-08 Cardiac Intelligence Corp. Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof
US6622050B2 (en) * 2000-03-31 2003-09-16 Medtronic, Inc. Variable encryption scheme for data transfer between medical devices and related data management systems
US6735479B2 (en) * 2000-06-14 2004-05-11 Medtronic, Inc. Lifestyle management system
US6669631B2 (en) * 2000-06-14 2003-12-30 Medtronic, Inc. Deep computing applications in medical device systems
US8145742B1 (en) * 2000-10-31 2012-03-27 Red Hat, Inc. Method of and apparatus for network administration
US6584352B2 (en) * 2000-12-27 2003-06-24 Medtronic, Inc. Leadless fully automatic pacemaker follow-up
US7224801B2 (en) * 2000-12-27 2007-05-29 Logitech Europe S.A. Wireless secure device
JP2002197186A (en) * 2000-12-27 2002-07-12 Fujitsu Ltd Personal information management device
US6662052B1 (en) * 2001-04-19 2003-12-09 Nac Technologies Inc. Method and system for neuromodulation therapy using external stimulator with wireless communication capabilites
FR2823883B1 (en) * 2001-04-23 2003-05-30 Ela Medical Sa METHOD FOR MANAGING CLINICAL PROTOCOL DATA RELATING TO THE USE OF ACTIVE IMPLANTABLE MEDICAL DEVICES
GB2375866B (en) * 2001-05-25 2005-02-09 At & T Lab Cambridge Ltd User interface systems
DE10247440B4 (en) * 2001-10-31 2005-05-04 Dr. Hein Gmbh Therapy system and therapy procedures
US6763269B2 (en) * 2001-11-02 2004-07-13 Pacesetter, Inc. Frequency agile telemetry system for implantable medical device
US7383088B2 (en) 2001-11-07 2008-06-03 Cardiac Pacemakers, Inc. Centralized management system for programmable medical devices
US7043305B2 (en) 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US20040122294A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with environmental data
US7546097B2 (en) * 2002-03-06 2009-06-09 Qualcomm Incorporated Calibration techniques for frequency synthesizers
US20040122487A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with composite parameter indices
US8043213B2 (en) 2002-12-18 2011-10-25 Cardiac Pacemakers, Inc. Advanced patient management for triaging health-related data using color codes
US7468032B2 (en) 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US8391989B2 (en) 2002-12-18 2013-03-05 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
US7983759B2 (en) 2002-12-18 2011-07-19 Cardiac Pacemakers, Inc. Advanced patient management for reporting multiple health-related parameters
US20030177031A1 (en) * 2002-03-15 2003-09-18 Medtronic, Inc. Data management of patient medical information for use with an implantable medical device
US20030220673A1 (en) * 2002-05-24 2003-11-27 Snell Jeffrey D. Multi-device telemetry architecture
US6978181B1 (en) 2002-05-24 2005-12-20 Pacesetter, Inc. Inter-programmer communication among programmers of implantable medical devices
DE60307882T2 (en) * 2002-10-31 2007-03-15 Medtronic, Inc., Minneapolis FAILSAFE PROGRAMMING OF AN IMPLANTABLE MEDICAL DEVICE
US7027871B2 (en) 2002-10-31 2006-04-11 Medtronic, Inc. Aggregation of data from external data sources within an implantable medical device
US7065409B2 (en) 2002-12-13 2006-06-20 Cardiac Pacemakers, Inc. Device communications of an implantable medical device and an external system
US7009511B2 (en) * 2002-12-17 2006-03-07 Cardiac Pacemakers, Inc. Repeater device for communications with an implantable medical device
US7127300B2 (en) 2002-12-23 2006-10-24 Cardiac Pacemakers, Inc. Method and apparatus for enabling data communication between an implantable medical device and a patient management system
US7395117B2 (en) 2002-12-23 2008-07-01 Cardiac Pacemakers, Inc. Implantable medical device having long-term wireless capabilities
US6978182B2 (en) 2002-12-27 2005-12-20 Cardiac Pacemakers, Inc. Advanced patient management system including interrogator/transceiver unit
US20040128161A1 (en) * 2002-12-27 2004-07-01 Mazar Scott T. System and method for ad hoc communications with an implantable medical device
US7378955B2 (en) * 2003-01-03 2008-05-27 Cardiac Pacemakers, Inc. System and method for correlating biometric trends with a related temporal event
US7742821B1 (en) 2003-06-11 2010-06-22 Boston Scientific Neutomodulation Corporation Remote control for implantable medical device
US7676385B2 (en) * 2003-02-18 2010-03-09 Mark Andrus Flood Method and equipment adapted for verifying presence of a medical implant within a patient
US20040215488A1 (en) * 2003-04-28 2004-10-28 Achim Hein Therapy system as well as therapy method
US7769465B2 (en) * 2003-06-11 2010-08-03 Matos Jeffrey A System for cardiac resuscitation
US9082156B2 (en) * 2005-08-17 2015-07-14 Jeffrey A. Matos Emergency management system
US8068917B2 (en) 2003-08-29 2011-11-29 Medtronic, Inc. Fail-safe programming for implantable medical device
DE202004021942U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US7180404B2 (en) * 2004-03-17 2007-02-20 Battelle Energy Alliance, Llc Wireless sensor systems and methods, and methods of monitoring structures
US7187299B2 (en) * 2004-03-17 2007-03-06 Battelle Energy Alliance, Llc Systems and methods for measuring a parameter of a landfill including a barrier cap and wireless sensor systems and methods
US20050222631A1 (en) * 2004-04-06 2005-10-06 Nirav Dalal Hierarchical data storage and analysis system for implantable medical devices
US20050228693A1 (en) * 2004-04-09 2005-10-13 Webb James D Data exchange web services for medical device systems
US20050251227A1 (en) * 2004-05-04 2005-11-10 Cardiac Pacemakers, Inc. Transferring software over a wireless radio frequency link onto external programmers for implantable medical devices
US7801611B2 (en) * 2004-06-03 2010-09-21 Cardiac Pacemakers, Inc. System and method for providing communications between a physically secure programmer and an external device using a cellular network
US7794499B2 (en) 2004-06-08 2010-09-14 Theken Disc, L.L.C. Prosthetic intervertebral spinal disc with integral microprocessor
US7433853B2 (en) * 2004-07-12 2008-10-07 Cardiac Pacemakers, Inc. Expert system for patient medical information analysis
WO2006010166A2 (en) * 2004-07-20 2006-01-26 Medtronic, Inc. Command sequencing and interlocks for a remotely programmable implantable device
US20060020491A1 (en) * 2004-07-20 2006-01-26 Medtronic, Inc. Batch processing method for patient management
US7418296B2 (en) * 2004-07-30 2008-08-26 Cardiac Pacemakers, Inc. Wireless pacing system analyzer in a programmer system
US8634926B2 (en) 2004-09-08 2014-01-21 Medtronic, Inc. Clinic based instrument system for remote processing and access to implanted systems information
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US9125667B2 (en) 2004-09-10 2015-09-08 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US20060064020A1 (en) * 2004-09-20 2006-03-23 Medtronic, Inc. Clinic dashboard monitor
US20060064136A1 (en) * 2004-09-23 2006-03-23 Medtronic, Inc. Method and apparatus for facilitating patient alert in implantable medical devices
US7840275B2 (en) 2004-10-01 2010-11-23 Medtronic, Inc. In-home remote monitor with smart repeater, memory and emergency event management
US8150509B2 (en) 2004-10-21 2012-04-03 Cardiac Pacemakers, Inc. Systems and methods for drug therapy enhancement using expected pharmacodynamic models
US7528094B2 (en) 2004-10-25 2009-05-05 Medtronic, Inc. Method and apparatus for providing safe long-range telemetry with implantable medical devices
US7580755B1 (en) 2004-11-19 2009-08-25 Pacesetter, Inc. Automatic data transmission rate adjustment
US20060155589A1 (en) * 2005-01-10 2006-07-13 Welch Allyn, Inc. Portable vital signs measurement instrument and method of use thereof
US20060161214A1 (en) 2005-01-20 2006-07-20 Patel Neilesh S Method of graphical display of link status and fail-safe mechanism for safety during real-time medical device therapy
US20100312129A1 (en) 2005-01-26 2010-12-09 Schecter Stuart O Cardiovascular haptic handle system
US20060167529A1 (en) * 2005-01-26 2006-07-27 Schecter Stuart O Method and algorithm for defining the pathologic state from a plurality of intrinsically and extrinsically derived signals
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US7526335B2 (en) * 2005-03-10 2009-04-28 Medtronic, Inc. Communications system for an implantable device and a drug dispenser
US20060206066A1 (en) * 2005-03-10 2006-09-14 Bozidar Ferek-Petric Communications system for an implantable device and a drug dispenser
WO2006102427A2 (en) 2005-03-21 2006-09-28 Defibtech, Llc System and method for presenting defibrillator status information while in standby mode
WO2006102425A2 (en) 2005-03-21 2006-09-28 Defibtech, Llc Environmentally responsive active status indicator system and method
WO2006102420A2 (en) 2005-03-21 2006-09-28 Defibtech, Llc Pcb blade connector system and method
US8438039B2 (en) 2005-04-27 2013-05-07 Medtronic, Inc. User customizable workflow preferences for remote patient management
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US20060287885A1 (en) * 2005-06-21 2006-12-21 Frick W V Treatment management system
US7780613B2 (en) * 2005-06-30 2010-08-24 Depuy Products, Inc. Apparatus, system, and method for transcutaneously transferring energy
US20070005141A1 (en) * 2005-06-30 2007-01-04 Jason Sherman Apparatus, system, and method for transcutaneously transferring energy
US7752059B2 (en) 2005-07-05 2010-07-06 Cardiac Pacemakers, Inc. Optimization of timing for data collection and analysis in advanced patient management system
US7818076B2 (en) * 2005-07-26 2010-10-19 Stereotaxis, Inc. Method and apparatus for multi-system remote surgical navigation from a single control center
US8827904B2 (en) 2005-08-31 2014-09-09 Medtronic, Inc. Automatic parameter status on an implantable medical device system
US8391975B2 (en) * 2005-09-28 2013-03-05 Medtronic, Inc. Telemetry of combined endocavitary atrial and ventricular signals
US20070073346A1 (en) * 2005-09-28 2007-03-29 Giorgio Corbucci Telemetry of combined endocavitary atrial and ventricular signals
US8116863B2 (en) 2006-03-21 2012-02-14 Defibtech, Llc System and method for effectively indicating element failure or a preventive maintenance condition in an automatic external defibrillator (AED)
US20070270660A1 (en) * 2006-03-29 2007-11-22 Caylor Edward J Iii System and method for determining a location of an orthopaedic medical device
US7496409B2 (en) * 2006-03-29 2009-02-24 Medtronic, Inc. Implantable medical device system and method with signal quality monitoring and response
US8075627B2 (en) 2006-04-07 2011-12-13 Depuy Products, Inc. System and method for transmitting orthopaedic implant data
US8015024B2 (en) * 2006-04-07 2011-09-06 Depuy Products, Inc. System and method for managing patient-related data
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
WO2008002783A2 (en) 2006-06-26 2008-01-03 Medtronic, Inc Local communications network for distributed sensing and therapy in biomedical applications
US7949404B2 (en) * 2006-06-26 2011-05-24 Medtronic, Inc. Communications network for distributed sensing and therapy in biomedical applications
WO2008022010A1 (en) 2006-08-18 2008-02-21 Medtronic, Inc Wireless communication network for an implantable medical device system
US20080046037A1 (en) * 2006-08-18 2008-02-21 Haubrich Gregory J Wireless Communication Network for an Implantable Medical Device System
US20080071328A1 (en) * 2006-09-06 2008-03-20 Medtronic, Inc. Initiating medical system communications
US8632464B2 (en) * 2006-09-11 2014-01-21 DePuy Synthes Products, LLC System and method for monitoring orthopaedic implant data
AU2007310986B2 (en) 2006-10-18 2013-07-04 Boston Scientific Scimed, Inc. Inducing desirable temperature effects on body tissue
AU2007310988B2 (en) 2006-10-18 2013-08-15 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US9996669B2 (en) * 2006-12-06 2018-06-12 Medtronic, Inc. Intelligent discovery of medical devices by a programming system
US7885712B2 (en) * 2006-12-06 2011-02-08 Medtronic, Inc. Medical device programming safety
WO2008070069A1 (en) * 2006-12-06 2008-06-12 Medtronic, Inc. Programming a medical device with a general purpose instrument
US8052610B2 (en) * 2006-12-28 2011-11-08 Medtronic, Inc. Event registration for automatic threshold setting
US8033998B2 (en) * 2006-12-28 2011-10-11 Medtronic, Inc. Device and method for automatic threshold setting
US8540642B2 (en) * 2007-01-31 2013-09-24 Medtronic, Inc. Implantable medical device and method for physiological event monitoring
US8000532B2 (en) * 2007-02-28 2011-08-16 Medtronic, Inc. Digital pen to capture data in ambulatory monitored patients
US8578118B2 (en) * 2007-04-26 2013-11-05 Medtronic, Inc. Scheme for overwriting stored physiological data in an implantable medical device
US7904153B2 (en) * 2007-04-27 2011-03-08 Medtronic, Inc. Method and apparatus for subcutaneous ECG vector acceptability and selection
US20080270036A1 (en) * 2007-04-27 2008-10-30 Webb James D Systems and methods facilitating auxiliary analysis of data from implanted medical devices
US8080064B2 (en) * 2007-06-29 2011-12-20 Depuy Products, Inc. Tibial tray assembly having a wireless communication device
US20090063193A1 (en) * 2007-08-31 2009-03-05 Mike Barton Dashboard diagnostics for wireless patient communicator
US9848058B2 (en) 2007-08-31 2017-12-19 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network employing dynamic communication link mapping
US8290791B2 (en) * 2008-07-29 2012-10-16 Medtronic, Inc. Patient management system
US8990924B2 (en) 2008-08-27 2015-03-24 Medtronic, Inc. Multiple user accounts for managing stored information in an implantable medical device system
AU2009314133B2 (en) 2008-11-17 2015-12-10 Vessix Vascular, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US8672917B2 (en) 2009-01-05 2014-03-18 Medtronic, Inc. Pressure monitoring to control delivery of therapeutic agent
US8790295B1 (en) 2009-01-05 2014-07-29 Medtronic, Inc. Pressure monitoring to control delivery of therapeutic agent
US8812841B2 (en) 2009-03-04 2014-08-19 Cardiac Pacemakers, Inc. Communications hub for use in life critical network
US8319631B2 (en) 2009-03-04 2012-11-27 Cardiac Pacemakers, Inc. Modular patient portable communicator for use in life critical network
CN102858405B (en) 2010-02-12 2015-08-19 布里格姆女子医院有限公司 The system and method that cardiac resynchronization therapy controling parameters regulates automatically
KR20130108067A (en) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8301232B2 (en) 2010-06-08 2012-10-30 Alivecor, Inc. Wireless, ultrasonic personal health monitoring system
US8700137B2 (en) 2012-08-30 2014-04-15 Alivecor, Inc. Cardiac performance monitoring system for use with mobile communications devices
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US8532775B2 (en) 2011-02-18 2013-09-10 Medtronic, Inc. Modular medical device programmer
CN103370099B (en) 2011-02-18 2016-01-13 美敦力公司 There is the medical treatment device programmable device of adjustable support
US8942828B1 (en) 2011-04-13 2015-01-27 Stuart Schecter, LLC Minimally invasive cardiovascular support system with true haptic coupling
US9510763B2 (en) 2011-05-03 2016-12-06 Medtronic, Inc. Assessing intra-cardiac activation patterns and electrical dyssynchrony
CN103813745B (en) 2011-07-20 2016-06-29 波士顿科学西美德公司 In order to visualize, be directed at and to melt transcutaneous device and the method for nerve
JP6106669B2 (en) 2011-07-22 2017-04-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. A neuromodulation system having a neuromodulation element that can be placed in a helical guide
US9643014B2 (en) 2011-07-29 2017-05-09 Medtronic, Inc. System and method for pacing parameter optimization using heart sounds
US20130053918A1 (en) 2011-08-30 2013-02-28 Aleksandre T. Sambelashvili Left-ventricular pacing site selection guided by electrogram morphology analysis
US8494631B2 (en) 2011-08-31 2013-07-23 Medtronic, Inc. System and method for profiling a patients hemodynamic response based on heart sounds
US10595813B2 (en) 2011-09-01 2020-03-24 Medtronic, Inc. Method and apparatus for monitoring cardiac and respiratory conditions using acoustic sounds
US8744560B2 (en) 2011-09-30 2014-06-03 Medtronic, Inc. Electrogram summary
US9668668B2 (en) 2011-09-30 2017-06-06 Medtronic, Inc. Electrogram summary
WO2013055826A1 (en) 2011-10-10 2013-04-18 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
WO2013058962A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Deflectable medical devices
US8868185B2 (en) 2011-10-31 2014-10-21 Medtronic, Inc. Use of thoracic and extra-thoracic impedance for diagnostic monitoring
US9597511B2 (en) 2011-10-31 2017-03-21 Medtronic, Inc. Method to assess hemodynamic performance during cardiac resynchronization therapy optimization using admittance waveforms and derivatives
EP2775948B1 (en) 2011-11-08 2018-04-04 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US8639333B2 (en) 2011-11-21 2014-01-28 Medtronic, Inc. Method and apparatus for adaptive cardiac resynchronization therapy employing a multipolar left ventricular lead
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9199087B2 (en) 2011-11-21 2015-12-01 Medtronic, Inc. Apparatus and method for selecting a preferred pacing vector in a cardiac resynchronization device
US9037238B2 (en) 2011-11-21 2015-05-19 Michael C. Soldner Method for efficient delivery of dual site pacing
WO2013082126A1 (en) 2011-11-29 2013-06-06 Medtronic, Inc. Use of thoracic and extra-thoracic impedance for diagnostic monitoring
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096916A2 (en) 2011-12-23 2013-06-27 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9560980B2 (en) 2012-01-31 2017-02-07 Medtronic, Inc. Automatic selection of electrode vectors for assessing risk of heart failure decompensation events
US9095718B2 (en) 2012-04-04 2015-08-04 Medtronic, Inc. Heart-sounds based adaptive cardiac resynchronization therapy timing parameter optimization system
US8583221B1 (en) 2012-04-26 2013-11-12 Medtronic, Inc. Method and apparatus for display of cardiac signal episodes with over- or under-sensing
US20130289378A1 (en) 2012-04-27 2013-10-31 Medtronic, Inc. Method and apparatus for cardiac function monitoring
US20130289640A1 (en) 2012-04-27 2013-10-31 Medtronic, Inc. Heart sound-based pacing vector selection system and method
US10660703B2 (en) 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US10013082B2 (en) 2012-06-05 2018-07-03 Stuart Schecter, LLC Operating system with haptic interface for minimally invasive, hand-held surgical instrument
US8521269B1 (en) 2012-06-27 2013-08-27 Medtronic, Inc. Determining tachyarrhythmia detection parameters based on prior detected episodes
US10099063B2 (en) * 2012-07-02 2018-10-16 Physio-Control, Inc. Medical monitor-defibrillator with defibrillator and data operations processors
US8868182B2 (en) 2012-07-16 2014-10-21 Medtronic, Inc. Device based cardiac monitoring and stress test
US8761717B1 (en) 2012-08-07 2014-06-24 Brian K. Buchheit Safety feature to disable an electronic device when a wireless implantable medical device (IMD) is proximate
US10321946B2 (en) 2012-08-24 2019-06-18 Boston Scientific Scimed, Inc. Renal nerve modulation devices with weeping RF ablation balloons
US9173696B2 (en) 2012-09-17 2015-11-03 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
CN104869930B (en) 2012-10-10 2020-12-25 波士顿科学国际有限公司 Renal neuromodulation apparatus and methods
KR102037416B1 (en) 2012-12-17 2019-10-28 삼성전자주식회사 Method for managing of external devices, method for operating of an external device, host device, management server, and the external device
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9956033B2 (en) 2013-03-11 2018-05-01 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9278219B2 (en) 2013-03-15 2016-03-08 Medtronic, Inc. Closed loop optimization of control parameters during cardiac pacing
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9297845B2 (en) 2013-03-15 2016-03-29 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US10064567B2 (en) 2013-04-30 2018-09-04 Medtronic, Inc. Systems, methods, and interfaces for identifying optimal electrical vectors
US9931048B2 (en) 2013-04-30 2018-04-03 Medtronic, Inc. Systems, methods, and interfaces for identifying effective electrodes
CN103315708A (en) * 2013-05-21 2013-09-25 美合实业(苏州)有限公司 Remote monitoring system for family members of patients and doctors
US9877789B2 (en) 2013-06-12 2018-01-30 Medtronic, Inc. Implantable electrode location selection
US10251555B2 (en) 2013-06-12 2019-04-09 Medtronic, Inc. Implantable electrode location selection
US9486151B2 (en) 2013-06-12 2016-11-08 Medtronic, Inc. Metrics of electrical dyssynchrony and electrical activation patterns from surface ECG electrodes
CN105473092B (en) 2013-06-21 2019-05-17 波士顿科学国际有限公司 The medical instrument for renal nerve ablation with rotatable shaft
EP3010437A1 (en) 2013-06-21 2016-04-27 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
WO2015002787A1 (en) 2013-07-01 2015-01-08 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
EP3019106A1 (en) 2013-07-11 2016-05-18 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
WO2015006480A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015010074A1 (en) 2013-07-19 2015-01-22 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
US10695124B2 (en) 2013-07-22 2020-06-30 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US9282907B2 (en) 2013-07-23 2016-03-15 Medtronic, Inc. Identification of healthy versus unhealthy substrate for pacing from a multipolar lead
US9272148B2 (en) 2013-07-23 2016-03-01 Medtronic, Inc. Combination of feedback on mechanical and electrical resynchronization to select therapy parameters
US9278220B2 (en) 2013-07-23 2016-03-08 Medtronic, Inc. Identification of healthy versus unhealthy substrate for pacing from a multipolar lead
US9265955B2 (en) 2013-07-26 2016-02-23 Medtronic, Inc. Method and system for improved estimation of time of left ventricular pacing with respect to intrinsic right ventricular activation in cardiac resynchronization therapy
US9265954B2 (en) 2013-07-26 2016-02-23 Medtronic, Inc. Method and system for improved estimation of time of left ventricular pacing with respect to intrinsic right ventricular activation in cardiac resynchronization therapy
WO2015027096A1 (en) 2013-08-22 2015-02-26 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
EP3041425B1 (en) 2013-09-04 2022-04-13 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
WO2015038947A1 (en) 2013-09-13 2015-03-19 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
CN105592778B (en) 2013-10-14 2019-07-23 波士顿科学医学有限公司 High-resolution cardiac mapping electrod-array conduit
AU2014334574B2 (en) 2013-10-15 2017-07-06 Boston Scientific Scimed, Inc. Medical device balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636538B (en) 2013-10-18 2019-01-15 波士顿科学国际有限公司 Foley's tube with flexible wire and its correlation technique for using and manufacturing
CN105658163B (en) 2013-10-25 2020-08-18 波士顿科学国际有限公司 Embedded thermocouple in denervation flexible circuit
US9320446B2 (en) 2013-12-09 2016-04-26 Medtronic, Inc. Bioelectric sensor device and methods
US9986928B2 (en) 2013-12-09 2018-06-05 Medtronic, Inc. Noninvasive cardiac therapy evaluation
WO2015103617A1 (en) 2014-01-06 2015-07-09 Boston Scientific Scimed, Inc. Tear resistant flex circuit assembly
WO2015106015A1 (en) 2014-01-10 2015-07-16 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
CN106102830B (en) 2014-01-10 2019-07-16 心脏起搏器股份公司 For improving the method and system of the communication between medical device
JP6325121B2 (en) 2014-02-04 2018-05-16 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Alternative placement of temperature sensors on bipolar electrodes
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
US9776009B2 (en) 2014-03-20 2017-10-03 Medtronic, Inc. Non-invasive detection of phrenic nerve stimulation
US9189613B1 (en) * 2014-07-11 2015-11-17 Fitweiser, Inc. Systems and methods for authenticating a user with a device
US9591982B2 (en) 2014-07-31 2017-03-14 Medtronic, Inc. Systems and methods for evaluating cardiac therapy
US9586052B2 (en) 2014-08-15 2017-03-07 Medtronic, Inc. Systems and methods for evaluating cardiac therapy
US9764143B2 (en) 2014-08-15 2017-09-19 Medtronic, Inc. Systems and methods for configuration of interventricular interval
US9586050B2 (en) 2014-08-15 2017-03-07 Medtronic, Inc. Systems and methods for configuration of atrioventricular interval
US9468385B2 (en) 2014-08-22 2016-10-18 Medtronic, Inc. Visual representation of a cardiac signal sensing test
WO2016033197A2 (en) 2014-08-28 2016-03-03 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
US9597513B2 (en) 2014-10-24 2017-03-21 Medtronic, Inc. Sensing and atrial-synchronized ventricular pacing in an intracardiac pacemaker
US9592392B2 (en) 2014-10-24 2017-03-14 Medtronic, Inc. Sensing and atrial-synchronized ventricular pacing in an intracardiac pacemaker
US9468766B2 (en) 2014-10-24 2016-10-18 Medtronic, Inc. Sensing and atrial-synchronized ventricular pacing in an intracardiac pacemaker
US9750941B2 (en) 2015-01-23 2017-09-05 Medtronic, Inc. Criteria for determination of local tissue latency near pacing lead electrodes
US11253178B2 (en) 2015-01-29 2022-02-22 Medtronic, Inc. Noninvasive assessment of cardiac resynchronization therapy
ES2713231T3 (en) 2015-02-06 2019-05-20 Cardiac Pacemakers Inc Systems for the safe supply of electrical stimulation therapy
JP6510660B2 (en) 2015-02-06 2019-05-08 カーディアック ペースメイカーズ, インコーポレイテッド System and method for treating cardiac arrhythmias
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
US11285326B2 (en) 2015-03-04 2022-03-29 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10166396B2 (en) 2015-04-24 2019-01-01 Medtronic, Inc. Efficient delivery of multi-site pacing
EP4339825A1 (en) 2015-05-12 2024-03-20 Dexcom, Inc. Distributed system architecture for continuous glucose monitoring
US9656087B2 (en) 2015-07-31 2017-05-23 Medtronic, Inc. Delivery of bi-ventricular pacing therapy in a cardiac medical device and medical device system
US10195421B2 (en) 2015-08-12 2019-02-05 Medtronic, Inc. Epicardial defibrilation lead with side helix fixation and placement thereof
US10357159B2 (en) 2015-08-20 2019-07-23 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
EP3337558A1 (en) 2015-08-20 2018-06-27 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
CN108136189B (en) 2015-08-28 2021-10-15 心脏起搏器股份公司 System for behavioral response signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
EP3359251B1 (en) 2015-10-08 2019-08-07 Cardiac Pacemakers, Inc. Adjusting pacing rates in an implantable medical device
US10391313B2 (en) 2015-12-04 2019-08-27 Boston Scientific Neuromodulation Corporation Systems and methods for the development of therapy paradigms for neurological treatments
EP3389775B1 (en) 2015-12-17 2019-09-25 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
US20170189674A1 (en) 2016-01-04 2017-07-06 Medtronic, Inc. Medical electrical lead
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
WO2017136548A1 (en) 2016-02-04 2017-08-10 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
US10780279B2 (en) 2016-02-26 2020-09-22 Medtronic, Inc. Methods and systems of optimizing right ventricular only pacing for patients with respect to an atrial event and left ventricular event
US11219769B2 (en) 2016-02-26 2022-01-11 Medtronic, Inc. Noninvasive methods and systems of determining the extent of tissue capture from cardiac pacing
US10039469B2 (en) 2016-03-30 2018-08-07 Medtronic, Inc. Atrial arrhythmia episode detection in a cardiac medical device
US10045710B2 (en) 2016-03-30 2018-08-14 Medtronic, Inc. Atrial arrhythmia episode detection in a cardiac medical device
WO2017173275A1 (en) 2016-03-31 2017-10-05 Cardiac Pacemakers, Inc. Implantable medical device with rechargeable battery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10512784B2 (en) 2016-06-27 2019-12-24 Cardiac Pacemakers, Inc. Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management
WO2018009569A1 (en) 2016-07-06 2018-01-11 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
WO2018017226A1 (en) 2016-07-20 2018-01-25 Cardiac Pacemakers, Inc. System for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10368769B2 (en) 2016-07-27 2019-08-06 Medtronic, Inc. Automatic thresholds for atrial tachyarrhythmia detection in an implantable medical device
WO2018035343A1 (en) 2016-08-19 2018-02-22 Cardiac Pacemakers, Inc. Trans septal implantable medical device
CN109640809B (en) 2016-08-24 2021-08-17 心脏起搏器股份公司 Integrated multi-device cardiac resynchronization therapy using P-wave to pacing timing
EP3503970B1 (en) 2016-08-24 2023-01-04 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
US10905889B2 (en) 2016-09-21 2021-02-02 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
WO2018057626A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Implantable cardiac monitor
EP3532159B1 (en) 2016-10-27 2021-12-22 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
US10765871B2 (en) 2016-10-27 2020-09-08 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
US10463305B2 (en) 2016-10-27 2019-11-05 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
CN109890456B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
JP6843235B2 (en) 2016-10-31 2021-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Systems and methods for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
US10632313B2 (en) 2016-11-09 2020-04-28 Cardiac Pacemakers, Inc. Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
CN109996585B (en) 2016-11-21 2023-06-13 心脏起搏器股份公司 Implantable medical device with magnetically permeable housing and induction coil disposed around the housing
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
US10894163B2 (en) 2016-11-21 2021-01-19 Cardiac Pacemakers, Inc. LCP based predictive timing for cardiac resynchronization
US10881863B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with multimode communication
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
CN110234392B (en) 2017-01-26 2023-08-11 心脏起搏器股份公司 Leadless device with overmolded component
JP7000438B2 (en) 2017-01-26 2022-01-19 カーディアック ペースメイカーズ, インコーポレイテッド Human device communication with redundant message transmission
EP3573708B1 (en) 2017-01-26 2021-03-10 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
US10165125B2 (en) 2017-03-02 2018-12-25 Biosense Webster (Israel) Ltd. Remote control and interaction with implanted devices
US10532213B2 (en) 2017-03-03 2020-01-14 Medtronic, Inc. Criteria for determination of local tissue latency near pacing electrode
US10987517B2 (en) 2017-03-15 2021-04-27 Medtronic, Inc. Detection of noise signals in cardiac signals
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
CN111050841B (en) 2017-07-28 2023-09-26 美敦力公司 Cardiac cycle selection
WO2019023472A1 (en) 2017-07-28 2019-01-31 Medtronic, Inc. Generating activation times
US11065459B2 (en) 2017-08-18 2021-07-20 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
CN111107899B (en) 2017-09-20 2024-04-02 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
US11278727B2 (en) 2017-11-22 2022-03-22 Medtronic, Inc. Efficient delivery of multi-site pacing
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
EP3717059A1 (en) 2017-12-01 2020-10-07 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
WO2019108482A1 (en) 2017-12-01 2019-06-06 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
WO2019108830A1 (en) 2017-12-01 2019-06-06 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
US10433746B2 (en) 2017-12-22 2019-10-08 Regents Of The University Of Minnesota Systems and methods for anterior and posterior electrode signal analysis
US11419539B2 (en) 2017-12-22 2022-08-23 Regents Of The University Of Minnesota QRS onset and offset times and cycle selection using anterior and posterior electrode signals
US10799703B2 (en) 2017-12-22 2020-10-13 Medtronic, Inc. Evaluation of his bundle pacing therapy
US10492705B2 (en) 2017-12-22 2019-12-03 Regents Of The University Of Minnesota Anterior and posterior electrode signals
US10786167B2 (en) 2017-12-22 2020-09-29 Medtronic, Inc. Ectopic beat-compensated electrical heterogeneity information
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
US10874861B2 (en) 2018-01-04 2020-12-29 Cardiac Pacemakers, Inc. Dual chamber pacing without beat-to-beat communication
US10617318B2 (en) 2018-02-27 2020-04-14 Medtronic, Inc. Mapping electrical activity on a model heart
US10668290B2 (en) 2018-03-01 2020-06-02 Medtronic, Inc. Delivery of pacing therapy by a cardiac pacing device
US10918870B2 (en) 2018-03-07 2021-02-16 Medtronic, Inc. Atrial lead placement for treatment of atrial dyssynchrony
US10780281B2 (en) 2018-03-23 2020-09-22 Medtronic, Inc. Evaluation of ventricle from atrium pacing therapy
CN111886046A (en) 2018-03-23 2020-11-03 美敦力公司 AV-synchronized VFA cardiac therapy
US11058880B2 (en) 2018-03-23 2021-07-13 Medtronic, Inc. VFA cardiac therapy for tachycardia
CN111902187A (en) 2018-03-23 2020-11-06 美敦力公司 VFA cardiac resynchronization therapy
CN111902082A (en) 2018-03-29 2020-11-06 美敦力公司 Left ventricular assist device adjustment and evaluation
US11304641B2 (en) 2018-06-01 2022-04-19 Medtronic, Inc. Systems, methods, and interfaces for use in cardiac evaluation
US10940321B2 (en) 2018-06-01 2021-03-09 Medtronic, Inc. Systems, methods, and interfaces for use in cardiac evaluation
US10736509B2 (en) 2018-07-30 2020-08-11 Biosense Webster (Israel) Ltd. Dual frequency control for a physiologic monitor
CN112770807A (en) 2018-09-26 2021-05-07 美敦力公司 Capture in atrial-to-ventricular cardiac therapy
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11547858B2 (en) 2019-03-29 2023-01-10 Medtronic, Inc. Systems, methods, and devices for adaptive cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11497431B2 (en) 2019-10-09 2022-11-15 Medtronic, Inc. Systems and methods for configuring cardiac therapy
US11642533B2 (en) 2019-11-04 2023-05-09 Medtronic, Inc. Systems and methods for evaluating cardiac therapy
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5752976A (en) 1995-06-23 1998-05-19 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US5767791A (en) 1995-11-13 1998-06-16 Vitalcom Low-power circuit and method for providing rapid frequency lock in a wireless communications device
JP3493847B2 (en) 1995-11-15 2004-02-03 株式会社日立製作所 Wide-area medical information system
US5833623A (en) 1996-05-14 1998-11-10 Pacesetter, Inc. System and method for facilitating rapid retrieval and evaluation of diagnostic data stored by an implantable medical device
AU8938598A (en) 1997-03-27 1999-04-23 Medtronic, Inc. Implantable Medical Device Remote Expert Communications System For Coordina ted Implant And Follow-Up
US6283923B1 (en) 1998-05-28 2001-09-04 The Trustees Of Columbia University In The City Of New York System and method for remotely monitoring asthma severity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7088233B2 (en) 1998-10-23 2006-08-08 Royal Thoughts, Llc Personal medical device communication system and method
US7138902B2 (en) 1998-10-23 2006-11-21 Royal Thoughts, Llc Personal medical device communication system and method
US7103344B2 (en) 2000-06-08 2006-09-05 Menard Raymond J Device with passive receiver
WO2003006107A1 (en) * 2001-07-10 2003-01-23 Medtronic, Inc. Custom manufactoring of implantable medical devices
WO2003024322A1 (en) * 2001-09-19 2003-03-27 Menard Raymond J Personal medical device communication system and method
AU2009200638B2 (en) * 2008-02-19 2013-10-17 Codman Neurosciences Sarl Implant revision recognition by exchanging the revision data during transmission
EP2093666A1 (en) * 2008-02-19 2009-08-26 Codman Neuro Sciences Sàrl Implant revision recognition by exchanging the revision data during transmission
US8285386B2 (en) 2008-02-19 2012-10-09 Codman Neuro Sciences Sárl Implant revision recognition by exchanging the revision data during transmission
WO2010111489A3 (en) * 2009-03-27 2010-11-18 LifeWatch Corp. Methods and apparatus for processing physiological data acquired from an ambulatory physiological monitoring unit
US11382554B2 (en) 2010-06-08 2022-07-12 Alivecor, Inc. Heart monitoring system usable with a smartphone or computer
US9833158B2 (en) 2010-06-08 2017-12-05 Alivecor, Inc. Two electrode apparatus and methods for twelve lead ECG
US9649042B2 (en) 2010-06-08 2017-05-16 Alivecor, Inc. Heart monitoring system usable with a smartphone or computer
US9351654B2 (en) 2010-06-08 2016-05-31 Alivecor, Inc. Two electrode apparatus and methods for twelve lead ECG
US9254095B2 (en) 2012-11-08 2016-02-09 Alivecor Electrocardiogram signal detection
US10478084B2 (en) 2012-11-08 2019-11-19 Alivecor, Inc. Electrocardiogram signal detection
US9579062B2 (en) 2013-01-07 2017-02-28 Alivecor, Inc. Methods and systems for electrode placement
US9220430B2 (en) 2013-01-07 2015-12-29 Alivecor, Inc. Methods and systems for electrode placement
US9254092B2 (en) 2013-03-15 2016-02-09 Alivecor, Inc. Systems and methods for processing and analyzing medical data
US9681814B2 (en) 2013-07-10 2017-06-20 Alivecor, Inc. Devices and methods for real-time denoising of electrocardiograms
US9247911B2 (en) 2013-07-10 2016-02-02 Alivecor, Inc. Devices and methods for real-time denoising of electrocardiograms
US9420956B2 (en) 2013-12-12 2016-08-23 Alivecor, Inc. Methods and systems for arrhythmia tracking and scoring
US9572499B2 (en) 2013-12-12 2017-02-21 Alivecor, Inc. Methods and systems for arrhythmia tracking and scoring
US10159415B2 (en) 2013-12-12 2018-12-25 Alivecor, Inc. Methods and systems for arrhythmia tracking and scoring
US9839363B2 (en) 2015-05-13 2017-12-12 Alivecor, Inc. Discordance monitoring
US10537250B2 (en) 2015-05-13 2020-01-21 Alivecor, Inc. Discordance monitoring

Also Published As

Publication number Publication date
US6480745B2 (en) 2002-11-12
EP1244382A2 (en) 2002-10-02
US20010031998A1 (en) 2001-10-18
WO2001047597A3 (en) 2001-11-15
WO2001047597B1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
US6480745B2 (en) Information network interrogation of an implanted device
EP1241981B1 (en) Dynamic bandwidth monitor and adjuster for remote communications with a medical device
US6920360B2 (en) Large-scale processing loop for implantable medical devices
US6442432B2 (en) Instrumentation and software for remote monitoring and programming of implantable medical devices (IMDs)
EP1244994B1 (en) Central network to facilitate remote collaboration with medical instruments
US20050240246A1 (en) Large-scale processing loop for implantable medical devices
US9979810B2 (en) Enabling data communication between an implantable medical device and a patient management system
US6418346B1 (en) Apparatus and method for remote therapy and diagnosis in medical devices via interface systems
US20010037220A1 (en) Integrated software system for implantable medical device installation and management
JP4364644B2 (en) Method and apparatus for remotely programming an implantable medical device
US8791815B2 (en) System and method providing data exchange with a medical device for remote patient care
JP2007524175A (en) Advanced patient management and medication management systems and methods
WO2001048675A2 (en) Large-scale processing loop for implantable medical devices
EP1241982B1 (en) Integrated software system for implantable medical device installation and management

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

AK Designated states

Kind code of ref document: B1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

B Later publication of amended claims
WWE Wipo information: entry into national phase

Ref document number: 2000986575

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000986575

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP